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DNA methylation is a widely studied epigenetic modification that can influence 
the expression and regulation of functional genes, especially those related to aging, cancer 
and other diseases. The common goal of methylation studies is to find differences in 
methylation levels between samples collected under different conditions. Differences can 
be detected at the site level, but regulated methylation targets are most commonly clustered 
into short regions. Thus, identifying differentially methylated regions (DMRs) between 
different groups is of prime interest. Despite advanced technology that enables measuring 
methylation genome-wide, misinterpretations in the readings can arise due to the existence 
of single nucleotide polymorphisms (SNPs) in the target sequence. One of the main 
pre-processing steps in DMR detection methods involves filtering out potential SNP-related 
probes due to this issue. In this work, it is proposed to leverage the current trend of collecting 
both SNP and methylation data on the same individual, making it possible to integrate SNP 
data into the DNA methylation analysis framework. This will enable the originally filtered 
potential SNPs to be restored if a SNP is not actually present. Furthermore, when a SNP is 
present or other missing data issues arise, imputation methods are proposed for methylation 
data. First, regularized linear regression (ridge, LASSO and elastic net) imputation models 
are proposed, along with a variable screening technique to restrict the number of variables 
in the models. Functional principal component regression imputation is also proposed as an 
alternative approach. The proposed imputation methods are compared to existing methods 
and evaluated based on imputation accuracy and DMR detection ability using both real and 
simulated data. One of the proposed methods (elastic net with variable screening) shows 
effective imputation accuracy without sacrificing computation efficiency across a variety of 
settings, while greatly improving the number of true positive DMR detections.
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1. INTRODUCTION
1.1. EPIGENETICS AND DNA METHYLATION
Genetics is the study of heritable changes involving modifications of the DNA 
sequence that exhibit variation between individuals. It includes the study of gene expression, 
genetic changes and multiple gene interactions. Changes to the DNA sequence are called 
mutations, and there are different types including deletions, insertions and translocations. 
Mutations can sometimes lead to the malformation of proteins, which may lead to disease. 
For example, sickle cell disease is caused by a single nucleotide mutation in the HBB gene 
that provides instructions for making one part of hemoglobin (Schnog et al., 2004). On the 
other hand, epigenetics is the study of heritable changes that are not associated with any 
alteration of the DNA sequence. Although all cells in an organism contain the same genetic 
information, the expression of genes can differ between cells. For example, different cell 
types require different genes to be active to perform their functions. Gene expression is 
regulated by epigenetics through different mechanisms, such as histone modifications, DNA 
methylation and non-coding RNA (Wei et al., 2017).
1.1.1. Mechanisms of DNA Methylation. DNA methylation (DNAm) plays an 
important role in gene regulation. It is one of the most studied epigenetic modifications 
in human cells that can affect gene expression and preserve cellular states through cell 
division without actually changing the DNA sequence. A nucleotide on a DNA molecule, 
specifically a cytosine, is methylated when a methyl group ( - CH3) is added to the carbon-5 
position of a cytosine, forming 5-methylcytosine. In mammals, DNAm is almost exclu­
sively found in CpG dinucleotides (a compound comprised of two nucleotides, cytosine 
(C) and guanine (G)) (Moore et al., 2013). The "p" simply indicates that "C" and "G" 
are connected by a phosphodiester bond. In stem cells and in plants, methylation is also
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found in the context of CHG and CHH where H is either A, T or C. A modified cytosine 
was first discovered in mammals by Hotchkiss (1948), who hypothesized that it was 5- 
methylcytosine and that it existed naturally in DNA. DNA methylation was demonstrated to 
be involved in gene regulation and cell differentiation in the 1980s (Holliday and Pugh, 1975; 
Compere and Palmiter, 1981). Further studies have revealed the important role of DNA 
methylation in many biological processes; including genomic imprinting (Tycko, 1997), 
transposable element silencing (Hollister and Gaut, 2009), stem cell differentiation (Sheaf- 
fer et al., 2014), embryonic development (Messerschmidt et al., 2014) and inflammation 
(Bayarsaihan, 2011), as well as cancer (Bock, 2012) and several other diseases.
1.1.2. CpG Island. A CpG island is a short part of the DNA sequence with a 
higher frequency of the CG dinucleotides sequence than other regions. CpG islands are 
often defined as a region with at least 200 base pairs (bp), a C and G percentage greater 
than 50%, and an observed-to-expected CpG ratio greater than 60% (Ongenaert, 2010). 
More stringent criteria have been proposed because this definition was unable to distinguish 
CpG islands from certain DNA repeat structures. Takai and Jones (2002) define a CpG 
island as having a minimal length of 500 bp, an observed-to-expected CpG ratio greater 
than 65%, and a C and G content of more than 55% are required. This largely solves the 
repeat problem, with the drawback that CpG islands that are smaller than 500 bp can not be 
predicted.
CpG islands typically occur at or near the transcription start site of genes, particularly 
housekeeping genes, in vertebrates. About 70% of human gene promoters have high CpG 
concentrations (Saxonov et al., 2006). DNA is wrapped around histone proteins forming 
small, packaged sections called nucleosomes. One of the common features of CpG islands 
is that they have less nucleosomes than other parts of DNA. This is often associated with 
modified histones and results in enhancing gene expression (Tazi and Bird, 1990). The CG
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dinucleotides sequence is not typically methylated in the promoter region of active genes. 
By contrast, the CG dinucleotides sequences in the promoter region of inactive genes are 
usually methylated to suppress their expression (Vinson and Chatterjee, 2012).
1.1.3. DNA Methylation and Cancer. It is well recognized that DNA methylation 
is an important epigenetic factor influencing gene activities, including genomic imprinting, 
aging and carcinogenesis. Cancer cells must undergo a series of molecular-level events to 
have the ability to replicate without limitation, as well as to invade and metastasize (Hana- 
han and Weinberg, 2011). Hypomethylation describes the unmethylated state of CpG sites 
that are normally methylated (a decrease in methylation); whereas hypermethylation refers 
to the methylated state of CpG sites in a specific sequence that are normally unmethylated 
(an increase in methylation). In cancer, global hypomethylation is accompanied by hyper- 
methylation of specific genes. Hypermethylation in the promoter regions of certain genes 
can suppress the expression of their functional proteins, including known tumor suppressor 
genes, leading to the silencing of those genes (Wajed et al., 2001). Epigenome-wide DNA 
methylation studies have shown that the methylation within functional promoter areas was 
associated with an increased risk of breast cancer, while the methylation of genomic regions 
outside the promoters was associated with a decreased risk (Severi et al., 2014). However, 
global hypomethylation has also been associated with oncogenesis (Das and Singal, 2004). 
Studies are ongoing to investigate the relationship between methylation patterns across the 
genome and specific types of cancer.
1.2. DNA METHYLATION TECHNOLOGIES
1.2.1. Bisulfite Sequencing. The development of technologies to measure levels 
of DNA methylation throughout the genome has been substantial in the past 30 years. 
These technological advances allow for significant improvement in understanding the role 
of epigenetics in medicine and biology in general. One method to detect DNA methylation at 
individual CpG sites is Bisulfite Sequencing combined with next generation sequencing (BS-
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seq) or whole genome bisulfite sequencing (WGBS). The basic principle of this approach 
involves bisulfite conversion on the unmethylated cytosines. Bisulfite conversion is a process 
in which DNA is denatured and treated with sodium bisulfite. The unmethylated cytosines 
are converted to uracils, while methylated cytosines remain unchanged. Following this 
process, the DNA is then treated by PCR amplification where the uracils are converted to 
thymines (Frommer et al., 1992). Comparing the sequence of converted DNA to untreated 
DNA creates a methylation profile of the sample. BS-seq or WGBS is the most thorough 
and informative approach to measure methylation status, thus it is capable of revealing 
subtle methylation patterns, and it achieves the most comprehensive coverage of a genome.
However, BS-seq is a costly and time-consuming procedure because the whole 
genome is tested. Reduced representation bisulfite sequencing (RRBS) is an efficient 
alternative for analyzing the genome-wide methylation profiles on a single cytosine level 
(Meissner et al., 2005). RRBS examines a subset of the genome by using a restriction 
enzyme to extract regions with a high CG dinucleotides content. The amount of nucleotides 
required to sequence is only 1% of the genome. These fragments often cover key promoter 
regions and CpG islands. This makes RRBS more economical and efficient. Therefore 
RRBS is suitable for large-scale comparative methylation studies across different tissues of 
cell types. On the other hand, a limitation of RRBS is that it can miss some CG dinucleotides 
and have lower coverage of some regions.
1.2.2. Infinium Beadchips. Illumina has developed a novel bead array technology 
using silica microbeads. On the surface of each array, tiny silica beads are located in 
microwells and coated with multiple probes. Probes are a collection of DNA spots that are 
attached to the solid surface for hybridization with the labeled target. Different probes are 
attached to each bead (Steemers and Gunderson, 2005). Illumina Infinium BeadChips have 
provided an easy to use, time efficient and cost effective way to measure methylation levels. 
The technology was first introduced with the Infinium HumanMethylation27 BeadChip 
(HM27). Quantitative measurements of DNA methylation can be determined for 27,578
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CpG dinucleotides spanning 14,495 genes using the HM27 platform. Like BS-seq, the initial 
step is bisulfite conversion, in which only a small amount of genomic DNA is required. 
Next, each sample is amplified, enzymatically fragmented, purified and then applied to the 
BeadChips for hybridization. There are two bead types that correspond to each CpG locus: 
one for the methylated and the other for the unmethylated state. Then, the array is stained 
with fluorescent dye and the intensities are measured (Weisenberger et al., 2008).
In 2011, an updated array called the Infinium HumanMethylation450 BeadChip 
(HM450) became the most widely used method for DNA methylation profiling. The 
HM450 array features 485,577 probes in coding and non-coding DNA regions, covering 
94% of the CpG sites on the HM27 array. Coverage is targeted to gene regions with sites 
in the promoter region, 5’ UTR, first exon, gene body, and 3’ UTR of RefSeq genes. CpG 
islands, CpG sites outside of CpG islands, and some enhancer regions are also covered by 
the HM450 array, as well as differentially methylated sites identified in tumor versus normal 
and across several tissue types. Notably, The Cancer Genome Atlas (TCGA) (TCGA, 2021) 
consortium used the HM450 platform to profile more than 8500 samples from over 52 
different cancer types.
There are two types of probes (Infinium I and Infinium II) on the HM450 array. 
Both probe types have assay chemistry technologies that are utilized to enhance the depth 
of coverage for methylation analysis. An illustration of the two probe types can be found 
in Figure 1.1. The Infinium I assay, also used in HM27, employs two bead types per 
CpG locus: one for the methylated and one for the unmethylated states. The Infinium II 
design uses one bead type, with the methylated state determined at the single base extension 
step. The addition of the Infinium II design enables each of up to three CpG sites to be 
either methylated or unmethylated on the probe with no impact on the result for the queried 
site. For the HM450 BeadChip, about 30% of CpG sites are measured using Infinium I 
probes and 70% of CpG sites are measured by the Infinium II probes. In 2016, the new 
Illumina Infinium Methylation EPIC array was released that can provide DNA methylation
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Infinium I
Unmethylated locus Methylated locus
uj Unmethylated bead type uj Methylated bead type I I CpG locus Bisulfite converted DNA
Infinium II
Unmethylated locus Methylated locus
J  Single bead type [ | CpG locus y  v Bisulfite converted DNA
Figure 1.1. Two types of Infinium probes. The Infinium I probes (top) have two bead types: 
one for the methylated and one for the unmethylated states. The Infinium II probes (bottom) 
has one bead type with the methylated state determined at the single base extension step. 
Figure from Illumina (2012).
levels for a total of 863,904 CpG sites. The EPIC array includes over 90% of the HM450 
probes, as well as additional probes dedicated to the enhancers revealed by the Functional 
Annotation of the Mammalian Genome project (FANTOM5) and the Encyclopedia of DNA 
Elements project (ENCODE). FANTOM5 and ENCODE are both public research projects 
aiming to identify functional elements in the human genome. Overall, data from the EPIC 
array at single loci are highly reproducible across technical and biological replicates and 
demonstrate high correlation with HM450 and WGBS data (Pidsley et al., 2016). In this
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work, the HM450 platform is utilized since data are accessible from TCGA. However, the 
methods can be generalized to methylation data obtained by other technologies, such as the 
EPIC array, WGBS or RRBS.
1.3. SNP AND METHYLATION MICROARRAYS
A single-nucleotide polymorphism (SNP) is a single nucleotide substitution in the 
DNA sequence (Figure 1.2). Typically there are two possible nucleotides altering at a 
given position (Vignal et al., 2002). SNPs are a common type of genetic variation among 
other DNA sequence mutations such as deletions, insertions and translocations. A variant is 
classified as a SNP when more than 1% of the population does not share the same nucleotide 
at the specific position on the genome. In humans, the occurrence rate of SNPs is about 
0.1%, meaning that there is one SNP in every 1,200 to 1,500 base pairs (Shastry, 2002). 
SNPs can occur anywhere in the genome, including in the coding regions of genes where 
they could lead to the changes in gene function and expression. SNPs can be identified 
through hybridization-based or enzyme-based methods. A SNP array is one detection 
method based on the hybridization of the fragmented DNA sequence and the immobilized 
allele-specific oligonucleotide probes (LaFramboise, 2009). DNA methylation microarrays 
also have a connection to SNP arrays. DNAm arrays interrogate DNA methylation states by 
sodium bisulfite conversion which transforms an epigenetic difference between a modified 
cytosine (including 5-methylcytosine (5-mC) and 5-hydroxymethylcytosine (5hmC)) and 
an unmodified cytosine to a genetic C/T SNP (Frommer et al., 1992). Therefore, the DNAm 
microarrays are essentially SNP arrays because the Infinium arrays obtain the methylation 
intensity at a particular location by checking whether there is a C/T SNP present.
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Figure 1.2. Single nucleotide polymorphism (SNP). At the fourth base, a SNP is present. 
The DNA sequence varies within a population at this site.
1.4. PREPROCESSING OF METHYLATION DATA
1.4.1. Probe Filtering. Some probes on the Illumina methylation arrays (including 
the HM450 array used in this work) are prone to giving inaccurate values that do not represent 
the underlying methylation state. This can arise due to a number of different reasons, that 
are each considered for initial filtering. One way this can happen is when a probe is present 
in low quantities because of amplification artifacts or mutation, resulting in a mismatched 
intended sequence. Such probes should be filtered out since they mostly carry background 
noise. To distinguish signal from noise, detection p-values are used. The background 
distribution is assumed normal, and the parameters are estimated using negative control
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probes. The p-value is computed using a Z-test (Heiss and Just, 2019). A small detection 
p-value indicates that the measured intensity is very likely to be a true (significant) signal 
and not background noise. Typically, significance levels of 0.05 or 0.01 are used. A 
sample is considered a bad sample when over 10% of the probes are problematic based on 
the detection p-values, and should be removed from the analysis. Bead counts are also a 
consideration of the probe quality. Usually, probes with less than 3 beads in at least 5% of 
samples per probe are filtered out. A larger proportion of non-CpG-target probes (Probe 
ID starting with “ch”) are potentially cross-hybridizing probes. Cross-hybridization is the 
tendency for chains of nucleic acids to bind to other chains of nucleic acids that have similar 
but not identical sequences. This makes the results difficult to interpret (Reilly et al., 2006). 
Of the 3,091 non-CpG probes on the HM450 microarray, only 39% can be mapped with 
a perfect match to the correct genomic location annotated by Illumina (Chen et al., 2013). 
Thus, all non-CpG probes are filtered out. Moreover, there are 65 built-in SNP probes 
(Probe ID starting with "rs") querying high-frequency SNPs in the HM450 array for the 
purpose of quality control, and they are typically removed in preprocessing steps.
The existence of SNPs can affect DNA methylation readouts in the Infinium arrays. 
SNPs can increase mismatches close to the 3’ end of the probe sequence and interfere with 
successful extension. It can also change the CpG dinucleotide sequence and therefore the 
ability of cytosines to be methylated. A special case would be the presence of an actual 
C/T polymorphism instead of the C/T introduced by bisulfite conversion. Also, for a Type I 
Infinium probe, the color channel depends on the extension base. If a SNP is present in the 
extension base, a potential color change could happen. Specifically, the color switch can be 
caused by an A/G SNP but not an A/T SNP, because A and T bases are both labeled with 
red fluorophores, and C and G are labeled with green. Therefore, probes with any SNP of 
global minor allele frequency (MAF) over 1% and within 5 bp from their targets, Infinium
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I probes with putative color channel switching SNPs, and Infinium II probes with SNPs of 
global MAF over 1% affecting the extension base are suggested to be filtered out (Zhou 
et al., 2016).
When aligning probe sequences to the human genome, some probes map to multiple 
sites. It has been shown that probes with non-unique alignments display significantly 
greater variance in methylation levels than uniquely mapping probes (Nordlund et al., 2013). 
Therefore, the multi-hit probes are usually filtered out in the preprocessing step. Typically, 
probes located in chromosome X and Y are removed to avoid sex related methylation biases.
1.4.2. Normalization. As mentioned in section 1.2, the Infinium HumanMethyla- 
tion450 and the EPIC BeadChip use two different types of chemical assays for their probes. 
This probe design can potentially cause problems for data analysis if they are not handled 
properly. It is shown that Infinium I and II probes usually have different distributions 
of methylation values, and that Infinium II probes are relatively less accurate and more 
sensitive for detecting extreme methylation values (Dedeurwaerder et al., 2011). In order 
to eliminate the influence of different probe types, remove sources of technical variation 
between measurements, as well as cancel background noise of the data, several different 
normalization methods have been developed.
Quantile normalization (Bolstad et al., 2003), first used in gene expression data, uses 
the mean intensity of the probes with the same rank from all studied arrays to replace the 
intensity of a probe. This helps make the distribution of probe intensities the same for each 
array. A peak-based correction (PBC) method (Dedeurwaerder et al., 2011) estimates the 
methylation peaks for the two probe types separately, then rescales the Infinium II values 
according to the initial range of Infinium I. The subset-quantile within array normalization 
(SWAN) method (Maksimovic et al., 2012) is based on normalization methods from mi­
croarray gene expression platforms. An average quantile distribution is determined using a 
subset of probes defined to be biologically similar based on CpG content. The intensities of 
the remaining probes are then adjusted by interpolation onto the distribution of the subset
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probes. The yS-mixture quantile normalization (BMIQ) method (Teschendorff et al., 2013) 
decomposes the methylation profiles of Infinium I and Infinium II probes into two mixtures 
of three methylation states (unmethylated, partially methylated and fully methylated), and 
then quantile normalizes the three distributions of the Infinium II profile corresponding to 
those of the Infinium I profile.
1.5. DIFFERENTIAL METHYLATION TESTING
1.5.1. Site Level Testing. A common goal of methylation studies is to discover 
individual CpG sites that have significantly different methylation levels between different 
conditions (e.g., normal vs. disease). These differentially methylated sites can be of 
substantial importance for the identification of novel disease biomarkers. In recent years, 
many statistical methods were developed for different types of methylation data to detect 
differentially methylated CpG sites.
For BS-seq, data can be summarized as counts of methylated and unmethylated 
reads at any given site. Fisher's exact test (FET) was one of the first approaches used 
to detect differentially methylated sites (Lister et al., 2009). However, FET does not 
account for the inherent biological variation that is present across biological replicates 
and it assumes independence between cytosine sites. BSmooth (Hansen et al., 2012) is an 
alternative approach that uses a “signal-to-noise” statistic to quantify differential methylation 
evidence at individual CpG sites by combining top ranked differentially methylated cytosines 
(DMCs), which are found using a t-statistic approach with either a quantile or direct t-statistic 
cutoff. BSmooth is not used directly for inference of differential sites, but rather uses the 
site level statistics to find differentially methylated regions. The beta-binomial model is an 
alternative statistical model for replicated BS-seq DNA methylation measurements. The 
beta-binomial distribution is the binomial distribution in which the probability of success
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in each of n trials is not fixed but randomly drawn from a beta distribution. It can account 
for both sampling and epigenetic variability. The beta-binomial model is used by methylSig 
(Park et al., 2014) and others for site level differential methylation detection.
Different from the count-based data obtained from BS-seq, DNA methylation arrays 
provide fluorescence intensities that are quantified as the relative level of methylated and 
unmethylated probes. Specifically, two types of data are used for downstream analyses. 
The yS-value is an estimate of the methylation level using the ratio of intensities between 
methylated and unmethylated alleles. They range between 0 and 1. Ideally, a value of 0 
indicates that all copies of the CpG site in the sample were completely unmethylated, and 
a value of 1 indicates that every copy of the site was methylated. The yS-value is defined 
below:
max(Methylated, 0)
max(M ethylated, 0) + max(Unmethylated, 0) + a "
The a  in the denominator is used to stabilize the estimate when both the methylated and 
unmethylated intensities are low. The a  value is set to 100 by default. Note that after 
correcting for background noise, the methylated and unmethylated intensities may have a 
negative reading. To avoid this, max(Methylated, 0) and max(Unmethylated, 0) are used 
to reset any negative values to 0 .
The other commonly used methylation measure is called an M-value. It is calculated 
as the log2 ratio of the intensities of methylated probes versus unmethylated probes, as 
defined below:
I max(Methylated, 0) + a  \
2 \max(Unmeth ylated, 0) + a)
The a  (by default equals 1) in the calculation is added in order to prevent unexpected large 
changes due to small intensity estimation errors. M-values can range from negative infinity 
to positive infinity. When the methylated and unmethylated probes have the same intensity 
value, the M-value is 0. Positive M-values indicate more methylation is occurring than not.
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The a  value in the calculations of both yS-value and M-value is typically negligible 
due to the fact that more than 95% of CpG sites have intensities higher than 1000 (Du et al., 
2010) and thus it typically does not have a large impact on the calculated methylation level. 
The relationship between the M- and yS-values can be expressed as:
M = log2
1 -  S
(1.1)
Although the yS-values are useful for interpretation, there are some advantages to using the 
M-values for statistical analysis, such as homogeneity of variance (Du et al., 2010). Also 
M-values range from negative infinity to positive infinity, making it more suitable to use 
statistical methods that have a normality assumption. Thus, M-values are recommended by 
Du et al. (2010) for conducting differential methylation analysis.
Several statistical methods have been proposed for DNA methylation microarray 
data to identify cytosine sites with significant differential methylation, including CpGassoc 
(Barfield et al., 2012), MENT (Baek et al., 2013), IMA (Wang et al., 2012), and COHCAP 
(Warden et al., 2013). The limma method (Smyth, 2004) is an approach first developed 
for detecting differential expression in gene expression microarray data, but it can also be 
used to test for differential methylation in DNA methylation microarray data. This method 
is further described since it is used in downstream region level analysis employed in this 
work. For DNA methylation studies, as well as other genomic studies like gene expression, 
typically only a small number of biological replicates are available. However, the studies 
are very complex, involving different aspects of biological processes and a large number 
of variables. It is challenging to find statistically significant and precise features between 
different conditions. The limma method (Smyth, 2004) tried to solve this problem by 
fitting a linear model to the M-value of each genomic position, then using empirical Bayes 
methods to estimate moderated t-test statistics. Global parameters are estimated using all 
the variables at once, which enables the incorporation of correlated neighboring genomic
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features. The empirical Bayes approach is equivalent to shrinkage of the estimated sample 
variances toward a pooled estimate. It borrows information between probes in order to 
moderate the residual variances, and ensures that small sample inference can be conducted 
with reliable and stable results (Ritchie et al., 2015).
1.5.2. Region Level Testing. While there are benefits of analyzing differential 
methylation at the site level, there are reasons both biologically and statistically to test 
differential methylation at the region level. It is shown that strong correlation exists between 
CpG methylation levels over short distances. This correlation dissipates the further away 
sites are from each other, such that it is no longer detectable at sites over 1000 bp apart 
(Eckhardt et al., 2006). Differential methylation targets are most commonly clustered into 
short regions. So it is meaningful to look at the differential methylation at a region level. 
Also, when the difference in methylation is small and undetectable at the site level, the 
persistence in small methylation differences over a region will provide a higher power for 
detection.
1.5.2.1. Defining regions. There are two ways to define a region when performing 
region level differential methylation testing. The first approach is to use predefined regions. 
The density of probes on HM450 data varies across the genome, with higher coverage in 
the promoter regions of genes and CpG islands (Illumina, 2012), as shown in Figure 1.3. 
Some differential methylation region (DMR) detection methods, such as IMA, COHCAP 
and QDMR (Zhang et al., 2011), concentrate on high density areas using predefined regions, 
compromising only a subset of the HM450 probes. This approach may miss meaningful 
clusters outside the predefined ones, but it can reduce the number of tests that need to be 
accounted for when controlling the false discovery rate.
The second way to define regions is to use a post-hoc aggregation method based on 
the data. After conducting the initial analysis on each cytosine site, probes are included in 
a region if they have significant site level differential methylation and are within a certain
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Figure 1.3. HumanMethylation450 BeadChip coverage of different regions. Figure from 
Illumina (2012).
distance of other significant sites. Bumphunter (Jaffe et al., 2012) and DMRcate (Peters 
et al., 2015) both use this approach to define a region. These methods are described in more 
details below since they will be utilized in this work.
I.5.2.2. Testing methods. Many DMR testing methods have been developed, such 
as Bumphunter, DMRcate and ProbeLasso (Butcher and Beck, 2015). In this study, Bum­
phunter and DMRcate are used since they are the most commonly used statistical methods 
for DMR detection in HM450 data. These methods are briefly described in this section
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and further details are provided in Chapter 2. Bumphunter is a data analysis pipeline de­
veloped to identify DMRs associated with disease (Jaffe et al., 2012). A statistical model 
is developed to take into account batch effects, which are a potential problem in large scale 
and high throughput studies with many samples. Batch effects are the unnoticed correlation 
between subgroups of samples which may be caused by experimental environments, such 
as the temperature and humidity. First, a linear regression model regressing the methylation 
value on the group status is applied to model differential methylation between the case and 
the control groups at each CpG site. This model can also incorporate batch effects. The 
slope coefficient corresponding to the group variable is then smoothed using loess. Clus­
ters of consecutive probes for which coefficients higher than a predetermined threshold are 
identified as candidate regions (bumps). Permutation tests, which permute sample labels to 
create a null distribution of candidate regions, are then conducted to estimate the statistical 
significance of the candidate DMRs.
DMRcate is a data-driven approach that can be used with WGBS data as well as 
HM450 array data (Peters et al., 2015). First, a linear model is fit at each CpG site using the 
limma method (Smyth, 2004). A Gaussian kernel with bandwidth A is used to smooth the 
estimated test statistics. The Gaussian kernel is calculated with a standard deviation a  = C, 
where C is a scaling factor for the bandwidth. Smoothed test statistics are then modeled and 
a p-value is calculated for each site. DMRs are defined by grouping the significant CpG 
sites that are at most A nucleotides from each other.
1.6. MOTIVATION
Human genomes are complex and are regulated at multiple levels. Various types 
of genomic data offer different aspects of complicated biological processes. Due to recent 
advances in high-throughput technologies, multiple types of genomic data (e.g. gene 
expression, methylation, SNP) can be collected on the same individual. The Cancer Genome 
Atlas (TCGA) is one of the most comprehensive cancer genomics programs. TCGA hosts
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a database with genomic sequence, expression, methylation, and copy number variation 
data on over 11,000 individuals, with samples in over 30 different types of cancer. TCGA 
is led by the National Cancer Institute (NCI) and the National Human Genome Research 
Institute (NHGRI) to map genomic and epigenomic changes with the goal of accelerating 
new discoveries in cancer-related research and to improve the prevention and treatment 
of cancer (Wang et al., 2016). The International Cancer Genome Consortium (ICGC) is 
another genomic data consortium, which provides data on genomic, transcriptomic and 
epigenomic abnormalities, as well as somatic mutations in over 50 different cancer types 
(Hudson et al., 2010).
Integrating and combining multiple types of genomic data can provide researchers 
with deeper insights into complex biological processes and help scientists reveal disease 
mechanisms for exploration, prevention and treatment. However, it is challenging to com­
bine these different layers of information. This study focuses on the integration of DNA 
methylation and SNP data to maximize the utilization of genomic information and improve 
biologically meaningful discoveries. When analyzing DNA methylation data, SNP probes 
are filtered out in a preprocessing step based on the population minor allele frequency and 
their location relative to the target sites. Any potential SNP is filtered out for all individuals 
due to the potential issues they pose for measuring methylation accurately. However, for 
each individual, one may or may not have the specific allele associated with the SNP. When 
SNP data are available, researchers can use the information to recover probes that are not 
affecting the quality of the methylation array. For those probes that are actually influenced 
by SNPs, imputation methods are proposed and investigated. Missing data are a common 
issue in different areas, including biology, genomics, social sciences and financial studies. 
Handling the missing value problem simply by deleting the missing instances can result in 
losing useful information. Simple solutions such as replacing the missing value with the 
mean may falsely lower the variability. This research will develop sophisticated imputa­
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tion methods based on the specific data structure. The nature of DNA methylation data 
and the correlation between neighboring sites will be considered when imputing missing 
methylation values.
In this dissertation, imputation methods are proposed based on the characteristics 
of DNA methylation data and these are described in Chapter 2. Predictive models built 
under the regularized linear regression framework are used to impute the missing values. 
The shrinkage approaches for the regression models include ridge, LASSO and elastic net. 
Moreover, functional principal component analysis is applied to perform linear models as 
an alternative imputation method. The proposed methods are evaluated and compared to 
existing imputation methods via a simulation study and analysis of real data, described in 
Chapter 3. The natural structure of the DNA methylation data is retained by using the real 
data when conducting the simulation. Two types of DMRs are investigated to mimic the 
methylation patterns in human genome. The performance of the imputation methods are 
assessed in terms of imputation accuracy and DMR detection ability. Finally, in Chapter 4, 
a summary of the work and discussion of future research is provided.
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2. DATA AND METHODS
2.1. DATA
2.1.1. Data. In this research, Infinium HumanMethylation450 BeadChip (HM450) 
DNA methylation data on breast cancer patients were obtained from The Cancer Genome 
Atlas (TCGA) (TCGA, 2021). Measurements of methylation levels on 485,577 CpG sites 
were given for the normal tissue and tumor tissue of 86 individuals. For 3 individuals, 
methylation data were only available for the tumor tissue. The raw data (provided in 
.idat files) were downloaded using the DTT UI from National Institutes of Health, the 
user interface (UI) design version of the Data Transfer Tool (DTT). Single-nucleotide 
polymorphism (SNP) data on “Pathogenic Germline Variants in 10,389 Adult Cancers” 
(Huang et al., 2018) were acquired from Genomic Data Commons (GDC). BCFtools (Li 
et al., 2009), a tool to process binary variant call format (BCF) and variant call format 
(VCF) files, was used to extract information on the 89 individuals for this study from the 
compressed VCF file of the combined variant calls.
The methylation data were processed through the Chip Analysis Methylation Pipeline 
(ChAMP) (Tian et al., 2017) in Bioconductor version 3.12 and R version 3.6.3. In addition 
to the raw .idat files, a table stating the sample names and their treatment groups is also 
required. The treatment group is acquired from the "Sample" code of each sample’s TCGA 
barcode (Figure 2.1). In the code, ‘01’ indicates the tumor sample type and ‘11’ is the 
normal sample type.
Prior to analyzing the DNA methylation data, several pre-processing steps are 
needed. One of these steps involves filtering out probes for different reasons, as described 
in Chapter 1. First, the data are filtered based on the detection p-values. Detection p-values 
measure the likelihood that the total intensity of the probes is generated by a background
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Figure 2.1. The Cancer Genome Atlas (TCGA) barcode label explanation. Figure obtained 
from (TCGA, 2011). ‘TSS’ is short for tissue source site.
distribution. If the detection p-value is below a specified significance level, it means the 
observed value of total intensity is unlikely to be generated by the background noise, thus 
the probe is considered detected (Heiss and Just, 2019). In this study, any probe with 
detection p-values greater than 0.01 are filtered out (Hernandez-Vargas et al., 2010). The 
percentage of problematic probes (based on the detection p-values) for each sample is also 
monitored. When the proportion is above 0.1, the sample will be removed from the analysis. 
Probes with less than three beads in at least 5% of samples per probe are also filtered out. 
All non-CpG probes and multi-hit probes are removed due to potential cross-hybridization 
and misinterpretation they may cause on methylation levels. In this research, the probes on 
the sex chromosome are kept because all the samples are females. If the samples are from 
both sexes, the probes located in chromosomes X and Y are suggested to be filtered out to 
exclude possible sex bias (Ma et al., 2013). A normalization step is also required before 
further analysis in order to adjust the bias caused by probe types and technical variation. In 
this work, the peak-based correction (PBC) normalization (Dedeurwaerder et al., 2011) is 
applied to the datasets before DMR detection.
Both a real dataset and a simulated dataset are used to study and evaluate proposed 
imputation methods with respect to the potential SNP probes. To improve the computation 
time without losing generality, in the real data analysis, a piece on the genome of a reasonable 
length is considered for the analysis. A total of 7,987 probes with genomic locations between
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1 and 13,800,000 base pairs on Chromosome 1 is considered. In a typical analysis, the 
probes with a potential SNP are also recommended to be filtered out based on the list 
provided by Zhou et al. (2016). After performing the standard filtering criteria (including 
potential SNP probes), 6,838 probes are remaining for analysis on this segment. This set of 
probes is referred to as the incomplete dataset in the real data analysis.
The SNP filtering is based on the potential for an individual to have a SNP at a 
particular location based on population data. However, many individuals will not have a 
SNP but rather have the common variant in the population. In this research, SNP data are 
integrated into the filtering phase and each sample is checked to determine if they actually 
have a SNP or have the common variant at each potential location. This allows the recovery 
of probes that do not have an actual polymorphism. By integrating the SNP data of all 
the individuals into the filtering process, a dataset with the most information available is 
generated. This is called the complete data, which contain 7,668 probes. After this step, 
a list of DNA methylation probes that are actually affected by SNPs is obtained. These 
probes can not be recovered since they actually contain true SNPs. Imputation methods are 
developed to fill these positions in order to improve downstream analysis such as differential 
methylation region (DMR) detection.
2.1.2. Characteristics of DNA Methylation Data. Methylation is not a random 
process. Researchers have found that close neighboring CpG sites are likely to share the 
same methylation status (Sun et al., 2019). That is, the DNA methylation level of a given 
site is highly correlated with the methylation levels of neighboring probes. Neighboring 
probes are defined in terns of their physical proximity based on their genomic location 
on the chromosome (i.e., how far away in base pairs (bp) the sites are from each other). 
This phenomenon could be due to the working distance range of DNA methyltransferase 
(DNMT) in changing the methylation status of CpG sites (Jia et al., 2007). DNMT transfers 
the methyl group to DNA and could methylate two CpGs within its working distance range
22
in one binding event. The correlation may also be due to the influence of the nearby CpG 
sites in the recruitment of DNA methyltransferase or demethylase enzymes (Lovkvist et al., 
2016). Demethylase enzymes remove the methyl group from methylated CpG sites.
Figure 2.2. Correlation between co-methylation and spatial distance in genomic base 
pairs (bp). The methylation values represented by the orange dots are averaged over 
25,000 individual measurements. Grey dots represent CpG methylation values based on 
re-sampling of random CpG positions. Blue dots represent CpG methylation values based 
on re-sampling of amplicons (obtained by PCR amplification). Correlation between CpG 
methylation and spatial distance is not detectable at distances larger than 1,000 bp. Figure 
from Eckhardt et al. (2006).
Eckhardt et al. (2006) mentioned that the methylation level of nearby probes have a 
significant correlation over short (up to 1,000 bp) distances. As shown in Figure 2.2, the 
correlation decreases rapidly at 1,000 bp and beyond. In the following statistical analysis
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steps, it is important to consider the genomic position of each probe and the potential of 
neighboring correlation when performing model building, variable selection and missing 
value imputation.
2.2. MISSING VALUE PROBLEM
Missing data can happen for many reasons that are beyond the control of the ex­
perimenter. For example, missing data can arise due to technical errors, improper data 
collection, respondents refusing to answer (e.g., in surveys) or participants that drop out. 
For array based genomic technologies, missing values may be caused by image corruption 
or low resolution (Troyanskaya et al., 2001). Missing values in DNA methylation are in­
troduced due to various reasons, such as filtering out probes with low detection p-values 
or low bead count, as well as removing multi-hit and non-CpG probes (Maksimovic et al., 
2012). One of the main sources of missing DNA methylation data is due to filtering out 
SNP probes. Addressing this issue is the main focus of this work.
The missing data mechanisms are categorized into three classes by Rubin (1976). 
If the probability of a missing value's occurrence is the same for all cases, and there is 
no correlation between the missing and the observed data, the missing data are called 
missing completely at random (MCAR). If the probability of being missing is the same 
within a group of the data, then the missing data are called missing at random (MAR). 
MAR means that there might be systematic differences between the missing and observed 
data, but these differences can be explained by some observed variables. For example, in a 
clinical trial studying blood pressure, some records are missing. People using manual blood 
pressure monitors tend to not record their blood pressure reads, whereas the reads can easily 
be recorded and stored for automatic digital blood pressure monitor users. The missing 
percentage is different between people using different devices, but it can be explained by a 
variable separating the two groups. Moreover, the variable is not related to the value that is 
missing. A violation of the rule would be when people with higher blood pressure record
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their results but people with normal blood pressure don’t record as often. The missing 
rate is related to the blood pressure values. This situation is the third type of missing data 
mechanism, missing not at random (MNAR). Missing data are classified as MNAR when 
there is a relationship between the tendency of a value to be missing and its value.
The underlying missing data mechanism has an impact on the choice and perfor­
mance of different imputation methods. However, for real data, the missing mechanism 
cannot be revealed by studying the data itself. In order to make reasonable assumptions, 
knowledge of the data and the data collection process is required. Due to the randomness 
of experimental and technological errors, MCAR/MAR is assumed for the HM450 data. 
For example, the missing value is higher at the positions where probes fail to capture target 
sequence, but the missing pattern is independent of the value itself (Lena et al., 2019a).
2.3. IMPUTATION METHODS
2.3.1. Traditional Solution for Handling Missing Values. One of the most fre­
quently used solutions for the missing value problem is listwise deletion. In this approach, 
all cases with missing values will be omitted from an analysis. This default method is con­
venient, but it reduces the sample size radically and can waste potentially useful information 
present in the deleted entries. For example, an individual answering a survey many answer 
only part of the questions and useful information may be contained in the subset of data that 
is available for that subject. Also, when the missing pattern is not MCAR, listwise deletion 
introduces large bias to the estimated mean (Little and Rubin, 2002).
Depending on the data type, there are several other convenient approaches to address 
missing values. If the variable is quantitative, the missing data can be replaced by averaging 
the non missing observations of the variable over all samples. If the missing value is quali­
tative, the mode of the non-missing observations can be used. However, mean imputation 
is problematic because it will shrink the standard deviation of the original distribution, and 
disturb the relationship between variables (Van Buuren, 2018). For example, values that are
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imputed by a variable’s mean have almost no relationship with other variables. As a result, 
the correlation between variables is biased toward zero, which is not wanted in data analysis. 
In this research, the mean imputation method is applied on the missing methylation data 
to provide a basis for comparison to a commonly used and easy approach. For each CpG 
site, the missing values among the samples are replaced with the mean over the methylation 
values of the non-missing samples of the same group for that site. As a result, if a CpG site 
has more than one missing entry, they will have the same imputed value.
For longitudinal data, last observation carried forward (LOCF) and baseline ob­
servation carried forward (BOCF) are widely used to address missing values, especially 
in clinical trials. In the LOCF method, the value at the last time point prior to a subject 
dropping out is used as the imputed value for all later time points in the study. Assumptions 
of LOCF are strong, including the assumption that observations do not change when data 
are missing and that a single data point can be used to estimate a distribution of potential 
values (Molenberghs et al., 2014). BOCF instead uses the baseline value of an individual 
as the imputed value for any missing data in the time sequence. It is suggested that the 
effect of actual outcomes as well as the reason for the missing values should be investigated 
before choosing this approach (Liu-Seifert et al., 2010).
2.3.2. KNN Imputation. K-nearest neighbors (KNN) imputation was proposed by 
Troyanskaya et al. (2001) to handle missing values in gene expression microarray data. 
The gene expression data are arranged in a matrix with genes in the rows and samples or 
experiments in the columns. For a gene with a missing expression value in sample i, K 
other genes will be found, which have an expression value in sample i. The missing value 
is estimated by a weighted average of the selected K gene expression values in sample i. 
The weight is decided by the similarity of each gene to the gene with missing value. It 
is found that the method is insensitive to the exact number of K within the range of 5-20. 
Similarities are measured by calculating the Euclidean distance between two genes using 
the rest of samples other than sample i.
26
The idea of this method is applicable to DNA methylation imputation because it 
uses the summary value from similar genes. With methylation data, the missing value is 
estimated by a weighted average of methylation levels from K=10 CpG sites in the same 
sample with the missing value. The KNN method will be applied in this work as one of the 
comparison methods since it is a current approach in genomic literature. A drawback of 
the KNN method is when the missing rate is very high at a particular CpG site, the method 
fails when all the neighbors are missing in a particular position.
2.3.3. MethyLImp. In 2019, Lena et al. proposed a linear regression model for 
missing value imputation specifically for DNA methylation data. The idea aims to capture 
the correlation between methyation levels of CpG sites by a linear regression model. The 
missing values are imputed by iteratively performing linear regression on the available data. 
The methylation data are organized in matrix form, with each methylation probe (CpG site) 
being treated as a column variable and the rows correspond to each sample.
In the first step of methyLImp (Lena et al., 2019a), the first CpG site with missing 
values is found. The method also searches for other CpG sites which have missing values 
in the same samples as the first CpG site. The non-missing values for this site (or sites) are 
denoted as Yi and the missing values as Y2. The imputation goal is to find the estimates 
of Y2. Next, the cases with no missing value in the submatrix with only samples in Y1 
is denoted as X1. X2 is the matrix whose entries include the same columns (sites) as X1 
and same rows (samples) as Y2. An illustration of how these matrices are defined can be 
found in Figure 2.3. Any column (site) with missing values not included in Y1 and Y2 are 
not used in that specific imputation iteration. In this example, Y 1 is a two-column matrix 
instead of a vector. The missing values in site 1 and site 6 will be imputed together because 
samples with missing values are the same for those two sites.
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Sitel Site2 Site3 Site4 Sites Site6 Site7 Sites Site9 SitelO S ite ll
S a m p le  1 0 .1 2 8 7 0 .1 2 7 6  0 .1 2 2 3  0 .1 0 6 8  0 .0 3 9 5 0 .0 8 3 8 0 .1 0 3 8 0 .0 6 6 8  0 .1 9 1 7 N A 0 .2 5 0 2
S a m p le  2 0 .0 7 8 5 0 .0 9 2 0  0 .0 6 8 9  0 .0 6 3 3  0 .0 2 8 0 0 .1 5 0 0 0 .0 6 3 5 0 .0 4 4 1  0 .1 7 2 3 0 .0 9 7 4 0 .1 1 0 9
S a m p le  3 0 .6 0 5 6 0 .6 7 9 1  0 .4 8 1 0  0 .6 1 3 7  0 .0 7 4 3 0 .1 6 7 3 NA 0 .4 4 0 9  0 .1 1 6 3 0 .5 6 7 9 0 .5 5 8 5
S a m p le 4 NA 0 .0 9 5 2  0 .0 8 7 8  0 .0 8 5 4  0 .0 2 0 6 N A 0 .1 0 3 2 0 .0 7 9 4  0 .1 7 7 3 N A 0 .2 6 9 7
S a m p le  5 0 .1 8 4 2 0 .2 2 0 0  0 .1 9 3 5  0 .1 9 4 9  0 .0 3 9 9 0 .1 4 3 8 0 .1 7 8 8 0 .1 2 2 9  0 .1 8 5 5 0 .2 5 9 5 0 .3 4 4 3









































Figure 2.3. Example of the matrix definitions from the methyLImp method.
To address the limited range of the yS-values between 0 and 1, a logit function 
l o g i t (p) = log(y-p), p  e  [0,1] is applied on the Yj’s and the model is set up as:
l o g i t (Y) = X • a  +  e. (2.1)
Here Y corresponds to the Yi matrix, X is the Xi matrix, a  are the regression coefficients 
and e is the error term. The error term is assumed to be independently and identically 
distributed with a normally distribution. The coefficients a  of the regression model are 
estimated by using the pseudo-inverse of X:
a  =  X-1 • l o g i t  (Y).
The pseudo-inverse X 1 is computed using the singular value decomposition (SVD) of X 
(Golub and Reinsch, 1970).
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The SVD of an N x  p matrix X is:
X = UDV'
where U is an N x p matrix and V a p x p matrix. U and V are orthogonal to each other. 
D is a p x p diagonal matrix with entries d1 >  d 2 >  ... >  dp , and the entries are called the 
singular values of X.
Then, the Moore-Penrose pseudo-inverse (Penrose, 1955) has the form:
X-1 = VD-1U'
where D-1 is formed from D by taking the reciprocal of all the non-zero entries and leaving 
the zeros as they are.
After obtaining &, the estimates of a ,  the missing methylation levels are predicted 
as follows:
Y2 = l o g i t -1(X2 • a ).
In summary, the MethyLImp method uses X1 and Y1 to build a regression model and then 
predicts the missing values in Y2 by fitting X2 in the model. An R-package implementing this 
method called ‘methyLImp’ is available at GitHub (Lena et al., 2019b). Lena et al. (2019a) 
compared methyLImp to existing methods including mean, KNN, SVDmiss (Fuentes et al., 
2006), softImpute (Mazumder et al., 2010), imputePCA (Husson and Josse, 2013) and 
missForest (Stekhoven and Buhlmann, 2012). MethyLImp was shown to perform equally or 
better than these methods and with good computational efficiency. The imputation methods 
proposed in this work are compared to methyLImp since it is the primary imputation method 
for DNA methylation data available.
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2.4. REGULARIZED LINEAR REGRESSION IMPUTATION
The number of CpG sites in DNA methylation data is much larger than the sample 
size. For example, HM450 methylation data has over 450,000 probes but the sample size 
in most studies is usually limited to around 100 individuals. When using a regression 
model to impute missing values, this high dimensional problem is not negligible in the 
models. A common problem of models with a large number of variables is multicollinearity. 
Multicollinearity is the condition where two or more predictor variables in a statistical model 
are linearly related (Dormann et al., 2013). The existence of multicollinearity can result 
in increased variance of regression coefficients, which will lead to unstable estimation of 
parameter values. For least squares regression, the regression coefficients a  are estimated 
as a = (X'X)-1X'Y, where X is the design matrix and Y is the response vector. When the 
columns of the design matrix X are highly correlated, X'X is almost singular, leading to the 
instability of a  with small changes in the data.
Regularized linear regression imputation is proposed in this research to deal with 
the issues posed by high dimensional data. The regularization approach involves adding a 
constraint to the loss function. A loss function is used to penalize the prediction errors when 
fitting the model (Hastie et al., 2009). For example, assume f  is the function to predict Y 
based on the input X . A convenient loss function is the squared error loss:
l = (Y -  f  (X))2. (2.2)
Least square estimators are obtained by minimizing the squared error loss function. Regu­
larization methods involve adding different penalty terms to the loss function, which prevent 
coefficients from taking unreasonable values and help with the risk of overfitting. Three 
different regularization methods (ridge regression, LASSO and elastic net) are explored in 
this work for incorporation into the imputation process as described below.
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The imputation methods in this research iteratively evaluate the complete subset of 
variables with missing entries. The iteration starts with the first CpG site measured on a 
chromosome and works sequentially through the genomic locations. Here, the variables 
are the methylation levels at different CpG sites. The input data is organized as each row 
representing a sample and each column representing a probe for a particular CpG site as 
shown in Figure 2.3. Several lists are generated: the list of all sample names S, all column 
names C, and the names of columns with missing values V . The first step is to find the 
variables with missing values V1 in V. Denote the list of row names of those missing 
positions of V1 as SNA. Yi is the vector or data matrix with columns V1 and rows in S but 
not in SNA. If the missing value positions are exactly the same for more than one variable, 
Yi will be a matrix instead of a vector. Xi is the submatrix with the same rows as Yi and 
the columns in C but not in V . X2 is the submatrix with the samples in SNA and same 
columns as in X1. Finally, Y2 is the vector or submatrix of missing values at variables 
V and samples in SNA. After obtaining Y1, X1, and X2 in the first iteration, methods are 
applied to fit a generalized linear model with Y1, X1, and then predict Y2 by feeding X2 into 
the fitted model. After the missing value(s) are imputed at variable(s) V1, the lists S, C, V 
and SNA are updated accordingly. The algorithm will search for the next variable(s) with 
missing values and the complete samples, and construct new vectors or matrices Y1, X1, 
and X2. In this step, the imputed values for variable V1 will be treated as complete entries. 
The iteration will stop when S and V are empty, meaning all the missing values have been 
imputed.
This work is inspired by methyLImp to impute missing values in DNA methylation 
data by utilizing a regression model. When forming the sub-matrices for imputation in 
the previous steps, the number of variables is large compared to the number of samples 
available, resulting in a high dimensional data problem. The proposed methods in this 
research use regularization when fitting the model instead of using the pseudo-inverse of 
the design matrix, which is not unique. To address the issues posed by high dimensional
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data, regularization (also known as shrinkage) approaches are used to shrink estimated 
coefficients towards zero relative to the least squares estimates to reduce the variance and 
help prevent overfitting (Hastie et al., 2009). Depending on the type of shrinkage approach, 
some of the coefficients may be estimated to be exactly zero. In this work, the two best- 
known regression regularization techniques (ridge regression (Hoerl and Kennard, 1970) 
and the LASSO (Tibshirani, 1996)) are employed in the imputation step that involves fitting 
a generalized linear model. An additional approach, the elastic net (Zou and Hastie, 2005), 
is also explored that combines the ridge and LASSO methods.
2.4.1. Ridge Regression. Ridge regression was proposed by Hoerl and Kennard 
(1970). By adding a small constant value A to the diagonal entries of X'X, the least 
square estimator’s stability can be improved. The ridge regression estimator is a ridge = 
(X'X + AIp)-1X'Y . Ridge regression shrinks the regression coefficients by imposing a 
penalty on their size:
N p p
a ridge = arg m in { ^ (y i -  ao -  ^  xijaj)2 + A ^  a j }. (2.3)
a i=i j=i j=i
The first component in Equation 2.3, £ =  (yi -  a0 -  Z p=1 xij a j )2, is typically called the 
residual sum of squares or the Sum of Squares Error (SSE) and it represents the squared 
error loss described previously. The second component of Equation 2.3, A Zp=1 a j , is 
referred to as the penalty term, which performs the shrinkage of the coefficients. A > 0 is 
the tuning parameter that controls the amount of shrinkage. The larger the value of A, the 
more shrinkage towards zero is applied to the coefficients. Equation 2.3 can equivalently 
be written as:
N p
a ridge = arg min V (yi -  ao -  V xij aj )2 (2.4)
“ i=1 j =1
z
j =1
a .2 £ '
subject to 12 penalty
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with a one-to-one correspondence between A and t . This approach works via the trade-off 
between bias and variance. A small bias is allowed in the coefficient estimates to reduce 
the variance and make the estimates more stable.
The R package ‘glmnet’ is used to do the regularization by the cyclic coordinate 
descent (CCD) method, which was developed by Friedman et al. (2010). To determine the 
tuning parameter A, 100 values are generated. Two parameters are needed for the sequence 
of A. The first one is the largest value for A such that all the coefficients are zero (denoted 
Amax). Note that Amax = m  for ridge regression, so a value is picked corresponding to the 
coefficients close to zero. The second one is a pre-determined ratio of the smallest value of 
the generated A sequence to Amax. When the number of samples is greater than the number 
of probes in the model, the ratio is set to be 0.0001. In this study, the number of probes is 
greater than the number of samples, thus the ratio is set to be 0.01 to increase the penalty 
for complexity. Amin is obtained by Amin =0.01 • Amax. The ten-fold validation error for each 
A value is computed. The tuning parameter with the smallest cross-validation error is used 
to fit the model for each iteration.
2.4.2. LASSO Regression. The least absolute shrinkage and selection operator 
(LASSO) was proposed by Tibshirani (1996), which is an l1 penalized least squares method 
for linear models. The residual sum of squares (SSE) is minimized with a constraint that 
the sum of the absolute values of the coefficients is less than a constant. This approach is 
similar to ridge regression, but the use of the l1 penalty instead of the l2 penalty can force 
certain coefficients to be zero. This is different from ridge regression which never sets the 
value of coefficients to be exactly zero. Ridge regression can be challenging for model 
interpretation, whereas LASSO yields a sparse model that results in variable selection by 
identifying the predictors with non-zero coefficients.
The LASSO estimate is defined by:
N p p
a LASSO = a rg m in { ^ (y  -  ao -  ^  xij aj )2 + A ^  | aj |},
a i=i j=i j=i
(2.5)
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where A is the parameter that controls the shrinkage. Equation 2.5 can also be written as:
N p
a LASSO _ arg minV (y  -  ao -  V Xij aj )2 (2.6)
a i_i j_i
subject to l1 penalty
aj \< t
with a one-to-one correspondence between A and t . This makes the solutions nonlinear in yi 
and there is no closed form expression as in ridge regression, so the minimization problem 
needs to be solved analytically. Efficient algorithms have been developed to compute the 
estimates of LASSO, such as the least angle regression algorithm (Efron et al., 2004). The 
same tuning procedures are adopted from ridge regression to choose the optimal value for 
A with ten-fold cross validation from a sequence of 100 generated A values. To generate the 
100 values, Amax is selected to be the value that makes all the coefficients zero.
To visualize differences in estimation for LASSO and ridge regression, consider the 
simple case when there are two variables with corresponding coefficients a 1 and a2. LASSO 
has the constraint function | a 1 | + | a2 \< t . This implies that LASSO coefficients have 
the smallest loss function for all points that lie within the square, given by \ a 1 \ + \ a2 \< t . 
Ridge regression has the constraint function ®2 + < t . Figure 2.4 shows the shape of the
constraint regions for LASSO (square) and ridge regression (circle), along with the contours 
of the residual sum of squares. If the sum of squares hits one of the corners of the square, 
then the coefficient corresponding to the axis is shrunk to zero.
If some of the probes have no correlation with the true methylation levels at the 
specified sites, LASSO outperforms ridge regression by shrinking the coefficients of those 
probes to zero. One limitation of LASSO occurs when there are two or more highly 
correlated sites and LASSO randomly selects one of them. In methylation data, multiple
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Figure 2.4. Estimation picture for LASSO (left) and ridge regression (right). The green 
areas are the constraint functions and the red curves are the contours for the least squares 
error functions. Figure modified from (Hastie et al., 2009).
CpG sites work together on a biological process and the correlation among them should be 
high. LASSO will only pick one site in the same group, making the model less interpretable 
by researchers since potentially important sites are filtered out.
2.4.3. Elastic Net Regression. A compromise between ridge and LASSO was 
proposed by Zou and Hastie (2005) as the elastic net penalty. The elastic net estimate is:
N p p
a enet = arg min { ^ ( y  -  ®o -  ^  Xijaj)2 + A ^ (0i | aj | +O2a j )} (2.7)
a i=i j=i j=i
where
01 + 02 = 1.
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Figure 2.5. Comparison of the constraint functions for ridge, LASSO and elastic net 
regression. The solid red line represents elastic net regression when 61 = 02 = 0.5. Figure 
from Zou and Hastie (2005).
The l1 penalty part of the elastic net generates a sparse model and the l2 penalty part 
removes the limitation of LASSO that can only select a limited number of variables. Thus, 
important variables that work together can be included in the model together. Moreover, it 
stabilizes the li regularization path. Compare the matrix form of the elastic net estimator:
&enet = argmin a'( — 2 )a -  2y'Xa  + A1 | a  |1 (2.8)
a 1 + A2
and the lasso estimator:
a LASSO = argmin a'(X'X)a -  2y'Xa + A1 | a  |1 (2.9)
a
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where J 1, J 2 are two fixed non-negative numbers. Note that Q1 = j j r ^  and 02 = jj+j^. 
D enote2 = X'X, which is the sample version of the correlation matrix 2. Notice the 
following term in Equation 2.8:
X'X + J2I
1 + J = (1 -  r ) 2 + y i
where y  = J 2/(  1 + J 2) shrinks 2 towards the identity matrix I . Equations 2.8 and 2.9 show 
that the elastic net penalization is equivalent to replacing 2 with its shrunk version in the 
LASSO.
A mixing parameter determines the type of penalty for regularization. As shown 
in Figure 2.5, the elastic net penalty is a mixture of the ridge and LASSO penalties. The 
mixing parameter is zero for ridge regression, one for LASSO regression and can vary 
between 0 to 1 for elastic net regression. In this research, the elastic net regularization 
method with the mixing parameters 0.2, 0.5 and 0.8 are explored. The same procedures 
to select the tuning parameter (J) are adopted from ridge regression. The optimal value 
for J  is chosen using ten-fold cross validation from a sequence of 100 generated J  values 
generated.
2.4.4. Summary. In this research, linear regression with regularized methods are 
proposed as imputation methods for missing DNA methylation data. As mentioned earlier in 
Section 2.4, for each CpG site with missing values, Y2 is imputed by generating predictions 
from applying X2 to model that was fit using X i and Y i. An improvement on imputation 
performance over methyLImp in terms of imputation accuracy is expected for the proposed 
methods because the potential problems caused by the nature of genomic data, such as high 
dimensionality and multicollinearity, are addressed. However, the computational efficiency 
is a challenge for the proposed methods because a ten-fold cross validation is required for 
parameter tuning for each iteration when fitting the model with Y i and a high dimensional 
X i. Section 2.5 describes the proposed solutions to handle this issue.
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2.5. REGULARIZED REGRESSION WITH VARIABLE SCREENING
In the linear model set up shown in Figure 2.3, the response variable Yi can be 
a matrix when the missing value positions are the same in more than one variable. The 
imputation will be performed using the same group of variables X1 for all the columns in 
Y1. However, in reality the variables in the submatrix Y1 are typically uncorrelated. Here 
a method to impute them individually instead of altogether is proposed. Additionally, the 
submatrices X1 and X2 involve thousands of variables, which make the computation cost 
very high. To solve this problem, an extra step is added in each iteration of the imputation 
process. After the formation of Y1, X1 and X2 (note here Y1 is always a vector), the 
dimensions of X1 and X2 are reduced to the length of Y1 (i.e., the number of samples) to 
get X i and X2. The selection is based on the Pearson correlation between the predictors 
and the response. Then, the regularization methods proposed in the previous section (ridge 
regression, LASSO, and elastic net regression) are applied to Y1 , X 1 and X2 to obtain 
imputed values for Y2. The steps for each imputation iteration are summarized below:
1. Matrices Y1, X1 and X2 are formed according to the description in Section 2.4 and 
Figure 2.3. Here, Y1 is a vector since each variable is imputed separately.
2. X 1 and X2 are obtained by reducing the dimensions of X1 and X2 to the length of Y1 
(i.e., the number of samples) using the Pearson correlation as a selection criteria.
3. A regularized linear regression model is fit using Y1 and X 1.
4. Y2 is predicted using X2 and the model in the previous step.
After each iteration, the algorithm will move to the next CpG site with missing value(s) and 
repeat the steps above until all missing entries are imputed.
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2.6. FUNCTIONAL DATA ANALYSIS IMPUTATION
The methylation level of each probe is dependent on the neighboring probes as 
described in Section 2.1.2. The methylation level values can be viewed as a curve over the 
genome. However, the previously described approaches do not incorporate this inherent 
ordering with neighboring dependency directly into the methodology. In this section, a 
functional data approach is proposed for imputation to address these issues. The basic 
concepts of functional data analysis (FDA) are introduced before proposing the functional 
principal component analysis (FPCA) imputation method.
The DNA methylation measurements for each sample can be treated as one single 
observation with underlying structure, rather than multiple observations of independent 
variables. The key assumption of functional data analysis is that there exists a function 
X  to represent the intrinsic structure of the data and the function is smooth. This can be 
expressed as:
Yij = Xi (tij) + €i,j (2.10)
where Yj represents the observed methylation level of individual i at the genomic location 
tij (i.e., CpG site), Xi(tij ) are the smooth functional data and ei,j is the error that account 
for "roughness" in the raw data. Here, i is the individual sample (i = 1 , . . . ,  n) and j  is the 
genomic location (j  = 1 , . . . ,  ni).
2.6.1. Basis Function. To approximate the data as a function, a basis function 
system is needed. A system of basis functions is a set of known functions, denoted as p k 
that are independent of each other. Let k = 1,2 ,3 ,..., K  where K  is the total number of 
basis functions. A linear combination of the basis functions constructs the desired function 
of the data as follows:
K




where ck are the coefficients corresponding to the basis functions 0k. Some common 
basis functions include the monomial system (1, t, t2, t3, . . .) ,  the Fourier series system 
(1, sin(mt), cos(mt), sin(2mt), cos(2mt), sin(3mt), cos(3mt),. . .) ,  and the exponential basis 
system (e^1t, e^2t, eX3t, . . .) (Ramsay and Silverman, 2007).
2.6.1.1. Fourier series. For periodic data, the Fourier series basis functions are 
commonly used, since the trigonometric sin and cos functions are periodic. Suppose the 
function repeats itself over a time period T, and let m = 2 n /T . The Fourier series basis 
functions are defined as follows:





05 (t) = cos(2mt)
06 (t) = sin(3mt)
0K (t) = cos(mmt).
The total number of basis functions is K  where K = 2m + 1. Fourier series have traditionally 
been used as basis functions in the past due to their computational efficiency. The Fourier 
basis is useful for extremely stable functions and ideally for data with some degree of 
periodicity (Ramsay and Silverman, 2007). However, this basis is not appropriate for data 
with discontinuities in the function or in low order derivatives of the function.
2.6.I.2. Splines. Often, non-periodic functions are approximated by spline func­
tions. Especially for data involving a large number of observations, spline function basis 
systems have been developed. Splines are polynomial segments joined end-to-end, but the 
segments are constrained to be smooth at the joining points. The joining points are called
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knots. The order m of the polynomial is the number of its highest power (degree) plus one. 
Being smooth at the breakpoints means the function values should be equal at these points. 
Further, the derivatives up to order m -  2 are also required be the same at the breakpoints. 
The spline function is determined by the order m of the polynomial segments and the knot 
sequence t1 where l = 1 , . . . ,  L -  1. The number of parameters needed is m + L -  1.
The B-spline basis system is the most popular spline system. It was developed 
by De Boor (2001). The B-spline basis system has the following properties: (1) Each 
basis function is a spline function defined by m and t , (2) any linear combination of the 
basis functions is a spline function, and (3) any spline function defined by m and t  can be 
expressed as a linear combination of these basis functions in the system. This system also 
has a compact support property, which states that a B-spline basis of order m is positive 
over no more than m intervals, and these intervals are adjacent. This property makes splines 
also computationally efficient.
2.6.2. Roughness Penalty. The coefficients of the B-spline functions can be deter­
mined by least squares estimation. Consider the error sum of squares (SSE):
n
SSE = J] (y j  -  X(tj))2. (2.13)
j = 1
Here the notation for the i index is removed for simplicity. To ensure the fitted curve is 
smooth, a simple linear smoother is obtained by finding the ck ’s that minimize the following 
least squares criteria:
n K
^ [ y j  -  Y j  ck<Pk(tj )]2. (2.14)
j=1 k=1
The method is suitable under assumptions that 6j’s in model 2.10 are independently and 
identically distributed with mean zero and constant variance.
Fitting the data and the smoothness of the curve are two competing desires. The 
least squares approach can be modified to incorporate a roughness penalty to address this 
issue. Roughness penalty methods for smoothing work by optimizing a fitting criterion
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by penalizing the roughness of the curvature. The curvature of a function at t can be 
characterized by the square of the second derivative (D2X (t))2. The roughness of a function 
can thus be defined as the integral of this value ^ (D 2X(t))2dt. A parameter A is used to 
control the roughness by minimizing the penalized squared error (PENSSE) (Ramsay and 
Silverman, 2007):
PENSSEa(X) = [(yj -  X(tj)]2 + A J  (D2X(t))2dt (2.15)
where DX(t) is the slope of X(t), D2X(t) = dLX(t) is the second derivative of X(t) and 
thus represents its curvature. A is a smoothing parameter measuring compromise between 
fit and smoothness. As A increases, the roughness will be penalized more and X(t) will 
become linear. As A decreases, the penalty is reduced and X(t) will fit the data better. The 
Smoothing Spline Theorem (Ramsay and Silverman, 2007) states that the function X(t) that 
minimizes PENSSEA (X) is a spline function of order 4 with a knot at each sample point t j . 
Therefore, unequal spacing of the sampling points is not a problem, since smoothing splines 
automatically take care of high density areas in the data and areas with fewer observations.
2.6.3. Functional Principal Component Analysis Imputation. Principal compo­
nent analysis (PCA) (Jolliffe, 2002) is a dimension reduction tool for multivariate data. 
Principal components are a new set of variables where each component is a linear combina­
tion of the original variables. The weights in the first components are chosen to maximize 
variance. Each subsequent component maximizes remaining variation and is orthogonal to 
all other components. The principal components are computed and then used for a change of 
basis on the data. This allows the dominant modes of variation in the data to be represented 
in a small subset of components. Most of the time, the first few principal components are 
enough to explain the majority of the variability in the data, and the remaining principal 
components will be discarded, resulting in dimension reduction in the data. For an n x p  data 
matrix X , each column is a vector of observations on one variable. A linear combination a
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of the columns of matrix X: £ p=1 ajXj = X a is aimed to achieve maximum variance, where 
Var(Xa) = a'Sa and S is the covariance matrix. With the restriction a'a = 1, maximizing 
a'Sa provides the solution that a is a unit norm eigenvector of the covariance matrix S, 
with corresponding eigenvalue X’s. The covariance matrix S is a p x  p  real symmetric 
matrix, and thus should have exactly p real eigenvalues. The eigenvectors are defined to be 
orthonormal, such that ajaj* = 1 when j  = j * and 0 otherwise. This ensures each set of 
linear combination is uncorrelated. By using the top k largest eigenvalues, the data could be 
represented with most of the variance explained. X ak are called the principal components, 
the eigenvectors ak are called the principal component loadings.
PCA was extended to functional data and became widely used in functional data 
analysis to capture the dominant modes of variation in the smoothed curves. Functional 
principal component analysis (FPCA) converts infinite-dimensional functional data to a 
finite-dimensional vector of random scores. The underlying stochastic process can be 
represented by a finite sequence of uncorrelated random variables. These variables are 
called the functional principal component scores (FPC scores). Similar to PCA, usually 
only a finite subset of the sequence is used that captures most of the variation.
The following formulation illustrates how FPCA can be formulated in terms of 
DNA methylation data and used for imputation. Assume that the methylation levels across a 
chromosome have the pattern of function X , and X  has an unknown smooth mean function 
p (t) and a covariance function which is defined as:
cov(X (s )), X (t)) = G(s, t) (2.16)
where s, t e T, and T is the genomic location. G(s, t) can be expanded with the orthogonal 
expansion:
TO




where Xk is the set of eigenvalues and p k are the corresponding eigenfunctions that form an 
orthonormal basis set with a unit norm in l2. The underlying pattern for the ith sample can 
be expressed as:
TO
Xi(t) = y.(t) + ^  Qkpk(t) (2.18)
k= l
where p k is the kth eigenfunction, and
cik = J ( X i ( t ) -  Mt))pk(t)dt (2.19)
is a coefficient projecting (Xi -  n ) in the direction of p k.
The data Yi (tij ) is the j  th observation of the random function Xi (•) at a random 
genomic location tij , also denoted as Yj, which can be represented as:
TO
Yi(tij) = Xi(tij) + 6ij = ^ (tij) + ^   ̂cikp k(tij) + p / . (2.20)
k=l
Here eij represents the measurement random errors of the ith sample at j  th genomic location, 
and are assumed to be independent and identically distributed with mean 0 and variance 
a 2. From Equations 2.19 and 2.20, it can be shown that:
Yi (t) (Xi(t) -  ju(t))pk(t)dtpk(t) + 6. (2.21)
The infinite series in Equation 2.18 can be truncated by L such that the first L components 
explains at least tx x 100% of the total variance, that is:
y  l  x
L = min{L > 1 : > t x} (2.22)
Z,k=i Xk
where M  is the largest number of components with Xk > 0 and t x is a user defined threshold 
between 0 and 1. When the observations Y(tij) are missing for some j , the missing entries 
can be imputed by the predicted values Xi(t).
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G <p = X(p. (2.23)
The estimate of G is obtained by smoothing the empirical covariances (Yao et al., 2005). 
Then the eigen-decomposition procedure is applied to the covariance function estimate to 
get the estimated eigenvalues Xj and eigenfunctions <pk (t).
The estimate of cik cannot be calculated easily through the approximation of Equa­
tion 2.19 because if the number of repeated observations is small or if there are missing 
positions, the integral is not accurate. Also the true Xi(t) cannot be observed. The observa­
tions are Yi (tij ) = Xi (tij ) + eij and bias will be introduced if Xi is replaced by Yi. An approach 
first proposed by Yao et al. (2005) provides a solution to these issues of estimating the cik 's. 
The eigenfunction basis is estimated from the data, and functional principal component 
score estimates are obtained by a conditioning step. The assumption is that the functional 
principal component scores cik and the error term q j are jointly Gaussian. The conditional 
functional principal component scores are:
To estimate X (t), the estimated values of l (t), c j  and $ k(t) are needed. To find the
estimates of the eigenfunctions <p and eigenvalues X, the eigenequation can be expressed as:
E (cik | Yi) = Xk$'ikEy; (Yi -  ) (2.24)
where Xk is the k th eigenvalue, Yi = [Y (tii),. . . ,  Y (tin)]', V i =  [ l i  (to ) , . . . ,  l i  (tim )]', Q ik =  
[<pk (tii ), . . . ,  (pk (tim)]/, and S Yi is the covariance matrix of Y i , with dimension m x m . The 
^Y; is represented as:
E y; = cov(Y i, Y i) = cov(X i, X i) + a 2\ n (2.25)
In scalar form this is:
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(£ y,.)j,i = G(tij, tii) + $ji (2.26)
with 6jl = 1 if j  = i and 0 if j  ^  i .
The estimated scores in Equation 2.24 are obtained by:
ci,k = 4 ^ \ kt y1 (Yi -  &i) (2.27)
where &  = [& (tn), . . . ,  fit (tin.)]' is the estimate of ^  = [$k (til),. . . ,  $k (tm)]' is the 
estimate of 0 ik and t Yi is the estimate of t Yi. The estimated score Q,k will be used as the 
functional covariates to perform functional linear regression with a scalar response.
2.6.4. Functional Linear Models. In traditional linear regression models, the de­
pendent variable and the independent variables are scalars. One way to set up a functional 
linear model is with a scalar dependent variable yi, but replace the independent variables 
by a function x  (t):
yi = ao + J  xi(t)a(t)dt + q-. (2.28)
One functional linear regression approach is to regress Y on the principal component 
scores as functional covariates (Ramsay and Silverman, 2007), and it will be referred to as 
Functional Principal Component Regression (FPCR) in this dissertation. A subset of the 
100 nearest available probes to the probe with missing values is utilized in the modeling to 
capture a relevant set of neighboring probes. Yi is an n l x 1 vector of the samples with 
complete entries for the probes with missing values. Y2 is an n2 x 1 vector and it represents 
the missing entries that need to be imputed. X2 is the n2 x 100 matrix with data on the 100 
neighboring probes with complete data and with the same rows of Y2. X1 is an n1 x 100 
matrix sharing the same rows with Y1 and the same columns with X2.
The R package ’fdapace’ is used to find the principal component scores via the 
Principal Analysis by Conditional Estimation (PACE) algorithm (Yao et al., 2005). The 




, with local linear smoothers (Fan and Gijbels, 1996) for function and
X2
surface estimation. A one-curve-leave-out cross-validation is used to choose the smoothing 
parameter. The conditional expectation method is then used to estimate the FPC scores. 
Finally, the response Y1 is regressed on the functional principal component scores to build 
the functional linear model. The model is then used to predict Y2. After each iteration, the 
algorithm will search for the next CpG site with missing value(s). The process of FPCR 
model fitting and prediction will be repeated. Imputation is completed when there is no 
missing value remaining in the dataset.
2.7. DMR DETECTION
The proposed imputation methods based on regularized regression and FPCR will 
be compared with mean imputation, KNN imputation, as well as the methyLImp method. 
To evaluate these methods, imputation accuracy is important since it represents how close 
the imputed values are to the real values. However, the goal of imputation is to obtain 
statistically valid results from the incomplete data. Thus, the quality of the imputation 
should also be evaluated with respect to this ultimate goal of DMR detection. A simulation 
study will be conducted to evaluate the imputation accuracy, and more importantly, the 
influence of imputation on DMR detection. Bumphunter and DMRcate are commonly 
used methods for DMR detection that are used in this work to evaluate the imputation 
performance on DMR detection. An overview of these methods is provided below.
2.7.1. Bumphunter. The Bumphunter method implemented in the Bioconductor 
package ‘ChAMP’ is used to find DMRs. The statistical model used by Bumphunter is:
p q




where Yj is the epigenomic measurement at the j th genomic locus for individual i, tj 
denotes the location on the genome of the j  th locus, ^(tj) is the baseline level of epigenomic 
measurement, Xi is the condition of interest, J3(tj) measures the association between Xi and 
the epigenomic measurement Yij at location t j , Z ’s are potential measured confounders (e.g. 
sex, age, race), each column of Z represents a different confounder, yk(tj) is the effects of 
confounder k at locus t j , W represents potential unmeasured confounders or batch effects 
(e.g. temperature, humidity), ai,j is the effect of the unmeasured confounder l on locus t j , 
and ei,j is the unexplained variability.
In the Bumphunter analysis pipeine, the linear regression model 2.29 is fit by 
regressing the methylation value Yj on the group Xi to model differential methylation 
between the case and the control groups at each CpG site. The slope (3(tj) is then smoothed 
using the loess method with a smoothing window ranging from 300 to 900 base pairs 
to get the smoothed fi(t). For most genomic positions, the J3’s are zero because the 
methylation levels at these positions are not significantly different between groups. Each 
point is weighted based on the standard error obtained from the linear model. The smoother 
works well to reduce the effect of outliers. Clusters of consecutive probes for which all 
the smoothed fi(t) values that are greater than a predetermined threshold are identified 
as candidate regions (bumps) Rn, n = 1 , . . . ,  N . The maximum gap is a user determined 
distance. When neighboring probes are less than that distance, they will be included in one 
region. Next, clusters are defined using the following criteria: 1) the cluster has at least 4 
probes, and 2) the probes inside one cluster are all less than or equal to 500 base pairs. The 
99th percentile of the slope estimates is used as a cutoff to determine the candidate regions. 
This means the values of the estimate of the methylation profile above the cutoff or below 
the negated cutoff are treated as candidate regions.
Permutation tests, which permute sample labels to create the null distribution of 
candidate regions Rn, n = 1, . . . ,  N , are then conducted to estimate the statistical significance 
of the candidate regions. The regions that are produced in the permutations are considered
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null regions and can provide a null distribution for Rn . This method can solve the problem 
of correlated measurement errors, batch effects and so on. The number of resamples is 
set to be 10. Each of the 10 permutations will generate an estimated null distribution. 
The p-value is the percent of candidate regions obtained from the permutations that are as 
extreme as the observed region. False discovery rates (FDR) are calculated based on the 
p-values, and Q-value is defined as the minimum FDR at which the associated area may 
be called significant. The family-wise error rate (FWER) is also calculated, which is the 
proportion of permutations that had at least one region as extreme as the observed region.
2.7.2. DMRcate. The Bioconductor package ‘DMRcate’ is also used to find DMRs. 
At each CpG site, a linear model is fit using the limma (Smyth, 2004) method. The square of 
the t statistic Y = tj  is used as the local statistic at each site i. The use of the squared t statistic 
allows the method to obtain the magnitude between methylation levels of two groups instead 
the direction of effect. Gaussian smoothing is then applied to the test statistics using a given 
bandwidth A. Next, suppose there are n CpG sites on a chromosome; x\ < x2 < ••• < xn 
representing all the locations. A Gaussian smoother is used to smooth the Yi at locations 
xi for each chromosome. The Gaussian kernel weights are Kij = exp |  [xj a jj] j , where 
a  is the kernel scale factor, a  = A/C . The value for the bandwidth A is set to be 500. 
As mentioned in Section 2.1.2, the correlation on methylation levels between sites over 
longer distances is not noticable. C is also user defined, and is set to be 5. Smoothed test 
statistics are then modeled using the method of Satterthwaite (Satterthwaite, 1946), and a 
p-value is calculated for each site. Significant sites are reported after Benjamini-Hochberg 
adjustments on p-values. Finally, DMRs are defined by grouping the significant CpG sites 




In this chapter, an analysis based on real data as well as a simulation study are 
presented to evaluate the performance of the imputation methods proposed in this work 
compared to the existing methods. The DNA methylation data described in Section 2.1.1 
are utilized both for the real data analysis and to guide settings in the simulation study. 
The set-up of the simulation study is first described, followed by a discussion of how the 
imputation methods will be evaluated in both the real and simulated data. Results are then 
given for the real data followed by results for the simulation study.
Three existing methods (mean, KNN, methyLImp) are compared to the proposed 
methods on imputation accuracy and ability to detect true differentially methylated regions 
(DMRs). A total of 11 proposed methods are compared, which can be categorized into 
three groups. The first group includes the regularized methods: ridge regression (Ridge), 
LASSO, elastic net with 0.2 mixing parameter (elastic net 0.2), elastic net with 0.5 mixing 
parameter (elastic net 0.5), and elastic net with 0.8 mixing parameter (elastic net 0.8). 
The second group includes all of these regularized methods with variable screening and 
imputation on a site by site basis (1 by 1) rather than altogether. These methods are denoted 
the same as above with 1by1 at the end: Ridge 1by1, LASSO 1by1, elastic net 0.2 1by1, 
elastic net 0.5 1by1, and elastic net 0.8 1by1. The final alternative approach evaluated is 
the functional principal component regression (FPCR) method.
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3.2. SIMULATION STUDY
The purpose of the simulation study is to investigate the performance of the pro­
posed imputation methods on imputation accuracy and the ability to detect differentially 
methylated regions. It is important to simulate the data in a way that preserves properties 
of real methylation data. The HM450 dataset described in Section 2.1.1 is utilized to help 
create a simulated dataset with a realistic structure. The distribution of the HM450 probes 
is related to the length of each chromosome. As shown in Figure 3.1, Chromosome 1 has 
the most number of probes, Chromosome 6 has the second most number of probes and 
Chromosome Y has the least number of probes. For computational efficiency, simulation 
studies are performed on the 36,611 CpG probes located on the entire Chromosome 6. The 
86 Normal samples are preprocessed as previously described, resulting in 31,362 probes 
after the filtering steps. This is recognized as the incomplete dataset. Among the filtered 
probes, 5,076 probes are filtered out because of being potential SNPs. After integrating 
the SNP data from “Pathogenic Germline Variants in 10,389 Adult Cancers” (Huang et al., 
2018), 4,917 probes are restored since SNPs were not present in any of the samples. This 
provides the complete dataset with 36,279 probes. Thus, only 159 probes with true SNPs 
are excluded.
The next step involves identifying a set of regions in which methylation differences 
will be applied. To accomplish this, Adjacent Site Clustering (Sofer et al., 2013) is imple­
mented to find region clusters on Chromosome 6 of the 86 Normal samples. The algorithm 
merges a set of methylation sites wedged between two highly correlated CpG sites that are 
located physically close to each other along a chromosome. More specifically, the criteria 
is to merge two CpGs with Spearman correlation greater than 0.5 and are within 200 base 
pairs into a cluster. This resulted in 2,478 clusters (14,801 probes total) with 4 or more 
probes, among which 2,088 clusters contain 10 or fewer probes. 250 clusters are randomly
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Figure 3.1. The count of HM450 probes on each chromosome.
selected from the 2,088 clusters. It is found that 96 of these clusters have SNP probes that 
could be restored from the 4,917 probes. A differential methylation effect is added to these 
96 regions to evaluate the imputation techniques.
To ensure the nature of real data is well preserved, two key points are implemented 
in the simulation steps. First, real datasets from the same group (Normal group) are used 
as the base to add differential methylation effects. Moreover, the parameters used in the 
simulation process are derived from summarized results of the real data analysis between 
Tumor and Normal groups. The 86 Normal samples are randomly divided into two groups. 
Before introducing differentially methylated regions (DMRs), the two groups are compared 
using the DMR detection methods Bumphunter and DMRcate to make sure there is no DMR
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flagged. The yS-values are first converted to M-values using Equation 1.1. The M-values 
are not bounded between 0 and 1, thus after adding the differential methylation effects, the 
issue of out of limit values is avoided. An effect size of 1.5 is determined by comparing the 
difference between Tumor and Normal groups of the real data.
Figure 3.2. Histogram of the sizes for all 96 clusters selected to be DMRs. The number 
of probes in each cluster is marked on top of each bin. There are 46 clusters with 4 or 5 
probes, and 8 clusters with more than 20 probes.
The details of the cluster size for all 96 clusters selected to be DMRs are shown 
in Figure 3.2. It is a right skewed histogram, with more small clusters than large clusters. 
There are 46 clusters with 4 or 5 probes, and 8 clusters with more than 20 probes. To ensure 
the added treatment effects do not cancel out existing differences in M-values, for each CpG 
probe in the methylation cluster, the group means of the two groups are first compared. 
Treatment effects are then added to the group of probes with higher mean M-values.
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Previous studies have found that hyper- and hypomethylation can happen in the 
same regulatory region with one followed immediately by the other (Day et al., 2013). The 
methylation levels in the simulation are designed to mimic this situation in real data. For half 
of the clusters, a type 1 simulation is applied by adding a treatment effect of 1.5 to M-values 
of the probes with higher average M-values (Figure 3.3 a). In this case, values may be 
added to different treatment groups inside a cluster. For the other half of the clusters, a type 
2 simulation is applied as follows. The group mean of the M-values for each CpG probe 
in each cluster is compared. For the group which has more probes with higher M-values, 
a treatment effect of 1.5 is added to the M-values in the same group for the entire cluster 
(Figure 3.3 b).
3.3. EVALUATION CRITERIA
3.3.1. Evaluation of Imputation Accuracy. In both the real and simulated datasets 
a subset of the probes are randomly selected to be missing at different rates. It is important 
to evaluate how accurate the imputed values are compared to the true values for the different 
imputation methods. Performance of the imputation methods on accuracy are assessed by 
using four different measures (Lena et al., 2019a). These measures are used to evaluate 
imputation accuracy in both the real data and the simulated data imputation.
The imputed or predicted values are denoted as P, and the true values are denoted
as T . The Root Mean Square Error (RMSE) metric measures the square root of the average
squared difference between the predicted and the true values. It is the most widely used
metric for performance assessment of missing data imputation approaches and is given
below: ____________
Z?=i(Pi -  Ti)2RMSE (P, T ) =
n (3.1)
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a. An example of type 1 simulation clusters
33360000 33360500 33361000 33361500 33362000 33362500
Genomic Location
b. An example of type 2 simulation clusters
32035500 32036500 32037500 32038500
Genomic Location
Figure 3.3. Two types of simulation clusters. yS-values verses the genomic location are 
shown here to illustrate the effects added. Black dots represent the Normal group and red 
dots represent the Tumor group. The shaded areas are the differentially methylated clusters. 
a, the effects are added to the probes with higher average methylation levels between two 
groups. b, the effects are added to all the probes in a cluster.
The Mean Absolute Error (MAE) metric measures the average absolute difference between 
the predicted and true values. It provides the average error to expect on the imputed value. 
Note that by Jensen’s inequality, RMSE >MAE. The MAE is given below:
MAE (P, T) = Z?=1 \P i -  Ti | (3.2)
n
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The Pearson Correlation Coefficient (PCC) metric measures the amount of linear correlation 
between the predicted and true values. The PCC is given below:
PCC(P, T) =
Z U (P i -  P)(T -  T )) 
V^n=i(Pi -  p )2V z?=1 (t  -  t )2
(3.3)
where P and T represent the mean value of P  and T, respectively. The Mean Absolute 
Percentage Error (MAPE) metric expresses the accuracy as percentage of error on the true 
value. It gives an estimation of the error in terms of the magnitude of actual value. The 
MAPE is given below:
M APE (P, T) = 100 V  n ii= 1
I Pi -  Ti | 
I Ti |
(3.4)
Note that smaller values of RMSE, MAE, and MAPE indicate greater accuracy; whereas 
larger values of PCC are better.
3.3.2. Evaluation of DMR Detection. The goal of missing value imputation is to 
improve the ability to detect differentially methylated regions that are important and biolog­
ical meaningful. The simulation results will be compared with true DMRs to determine if 
there are any improvements with respect to true positive, false positive, and false negative 
regions. Note that true DMRs are unknown in the real data, so this evaluation is only con­
ducted for the simulated data. A true positive (TP) DMR is defined as a significant DMR 
declared by one of the detection methods (Bumphunter or DMRcate) that overlaps with a 
region in which a treatment effect was added to the methylation M-values. The overlap type 
is ‘any’, meaning any common genomic location between the compared regions will count 
as them as overlapping. A false positive (FP) DMR is defined as a significant DMR declared 
by one of the detection methods that does not overlap with any of the regions with added 
treatment effects. A false negative (FN) DMR is defined as a region with added treatment
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Table 3.1. Details of probes filtered out by each step of the default filtering process.
Filtering Step Probes Filtered Out Remaining Probes
quality control probes 65 485,512
detection p-value 25,900 459,612




effect that does not overlap with any significant DMRs found by the detection methods. It is 
possible that some true methylated regions are broken down into smaller regions for certain 
DMR detection methods, or that more than one true region is recognized as one DMR.
3.4. RESULTS FOR REAL DATA ANALYSIS
3.4.1. SNP Integration. Following the filtering steps in Section 2.1.1 for detection 
p-values, bead counts, SNP probes, multi-hit probes and non-CpG probes, a total of 485,577 
probes on the HM450 array are reduced to 402,935 probes. There are 65 built-in SNP 
probes in HM450 array for the purpose of quality control, and they are typically removed 
in preprocessing steps. The steps shown in Table 3.1 are sequential, meaning that each 
filtering step is based on the filtering result of previous step(s). For example, if the probes 
are filtered by bead count first, followed by detection p-value, the numbers in the second 
column would be different.
By integrating the germline SNP data, a large portion of probes are restored. As 
shown in Figure 3.4, 52,441 probes out of 53,959 (97.2%) are actually not SNP probes, thus 
it is not necessary to filter them out. With the large portion of probes being restored, the 
influence on DMR improvement is prominent. For the remaining 1,518 probes, imputation 
methods are developed and evaluated on these probes that cannot be restored.
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Figure 3.4. Details of probe restoration by integrating SNP data.
As briefly discussed in chapter 2, the dataset used for real data analysis is described 
below. Starting with a section of Chromosome 1 (7,987 probes between the genomic 
location 1 and 13,800,000), the filtering steps in Section 2.1.1 are conducted on the raw 
intensity files (idat). This step results in a dataset with 6,838 probes, and this dataset is 
noted as the incomplete data. After integrating the SNP data, 830 probes are restored. The 
dataset with 7,668 probes is called the complete dataset. Missing values are introduced 
in the 830 restored SNP probes at different missing rates. Imputation methods are then 
conducted to obtain the imputed dataset.
The imputation accuracy is compared between the true values and the imputed 
values. The DMR detection performance is evaluated using the complete dataset as a 
standard since the true DMRs are unknown for the real data. The complete dataset is the 
most informative since it utilizes the data from the most true probes possible for DMR 
detection compared to the incomplete and imputed datasets. In the next section, simulated 
data is used to assess the DMR detection improvements by imputation.
3.4.2. Im putation Accuracy. The performance of the imputation methods are 
compared by computing the RMSE, MAE, PCC and MAPE for each method. The im­
putation accuracy is assessed per CpG site. Three missing rates (20%, 50% and 70%) 
are explored. The Normal group and Tumor group are separated when conducting the
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imputation. Overall, imputation methods perform better on the Normal group than Tumor 
group, regardless of the detection method used or the missing rate. This likely due to the 
heterogeneous nature of tumor samples. Additional discussion about this issue can be found 
in Chapter 4.
Table 3.2 shows the performance with missing rate 20%. The performance of all 
imputation methods work uniformly better in the Normal group than the Tumor group. 
Take the mean imputation method as an example. The Tumor group has a RMSE of 0.116 
while the Normal group has a RMSE of 0.085. While the mean imputation has the largest 
RMSE in both groups, FPCR and KNN imputation perform only slightly better than mean 
imputation in the Tumor group. In the Normal group, the regularized linear regression 
imputation method using elastic net with mixing parameter 0.8 (elastic net 0 .8) has the 
smallest RMSE, MAPE and the highest PCC. The methyLImp, elastic net 0.2, elastic net 
0.8, LASSO 1 by 1, elastic net 0.2 1 by 1, elastic net 0.5 1 by 1 and elastic net 0.8 1 by 1 
methods have the smallest MAE. In the Tumor group, the elastic net 0.2 1 by 1, elastic net 
0.5 1 by 1 and elastic net 0.8 1 by 1 methods have the smallest RMSE, MAE and highest 
PCC. The elastic net 0.8 method has the smallest MAPE, followed by all three of the elastic 
net 1 by 1 methods.
Table 3.3 shows the performance of the imputation methods with missing rate 50%. 
While the mean method is still the worst, the performance of the KNN method becomes the 
next worst across all of the criteria in both groups. In the Normal group, all the regularized 
methods outperform methyLImp in terms of RMSE, PCC and MAPE. The LASSO, elastic 
net 0.2, elastic net 0.5, elastic net 0.8 and elastic net 0.2 1 by 1 methods have the lowest 
RMSE and highest PCC. The methyLImp, LASSO 1 by 1, elastic net 0.2 1 by 1, elastic net 
0.5 1 by 1 and elastic net 0.8 1 by 1 methods have the lowest MAE. The elastic net 0.2 1 by 
1 method has the lowest MAPE. In the Tumor group, the elastic net 0.2 1 by 1 and elastic
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Table 3.2. Imputation accuracy for real data with 20% missing rate. The optimal value(s)
for each criteria are in bold.
RMSE MAE PCC MAPE
mean 0.085 0.054 0.952 16.836
KNN 0.064 0.035 0.974 11.323
methyLImp 0.061 0.029 0.976 10.350
LASSO 0.059 0.030 0.977 9.965
Ridge 0.061 0.030 0.976 10.356
elastic net 0.2 0.056 0.029 0.979 9.652
Normal elastic net 0.5 0.059 0.030 0.977 9.957elastic net 0.8 0.056 0.029 0.980 9.625
FPCR 0.066 0.036 0.972 11.428
LASSO 1by1 0.059 0.029 0.977 9.853
Ridge 1by1 0.060 0.032 0.976 10.532
elastic net 0.2 1by1 0.059 0.029 0.977 9.872
elastic net 0.5 1by1 0.059 0.029 0.978 9.819
elastic net 0.8 1by1 0.059 0.029 0.977 9.799
mean 0.116 0.079 0.908 25.595
KNN 0.092 0.058 0.943 17.957
methyLImp 0.085 0.050 0.953 15.597
LASSO 0.083 0.050 0.955 14.989
Ridge 0.090 0.054 0.947 17.334
elastic net 0.2 0.083 0.050 0.954 14.499
Tumor elastic net 0.5 0.083 0.050 0.955 15.059
elastic net 0.8 0.083 0.050 0.955 14.214
FPCR 0.095 0.060 0.941 17.900
LASSO 1by1 0.082 0.048 0.956 14.451
Ridge 1by1 0.088 0.053 0.949 16.603
elastic net 0.2 1by1 0.081 0.048 0.957 14.418
elastic net 0.5 1by1 0.081 0.048 0.957 14.250
elastic net 0.8 1by1 0.081 0.048 0.957 14.382
net 0.5 1 by 1 methods have the lowest RMSE. The elastic net 1 by 1 methods with mixing 
parameter 0.2, 0.5 and 0.8 have the lowest MAE and highest PCC. The elastic net 0.2 1 by 
1 method has the lowest MAPE.
Table 3.4 shows the performance of all imputation methods with missing rate 70%. 
The KNN method performs the worst in terms of RMSE, MAE, PCC and MAPE. In the 
Normal group, the elastic net 0.2, elastic net 0.5, Ridge 1 by 1 and elastic net 0.2 1 by 1
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Table 3.3. Imputation accuracy for real data with 50% missing rate. The optimal value(s)
for each criteria are in bold.
RMSE MAE PCC MAPE
mean 0.084 0.053 0.953 16.742
KNN 0.067 0.038 0.971 11.664
methyLImp 0.062 0.030 0.975 11.469
LASSO 0.058 0.031 0.978 10.495
Ridge 0.059 0.031 0.977 10.725
elastic net 0.2 0.058 0.031 0.978 10.513
Normal elastic net 0.5 0.058 0.031 0.978 10.485elastic net 0.8 0.058 0.031 0.978 10.484
FPCR 0.064 0.036 0.973 11.078
LASSO 1by1 0.059 0.030 0.977 9.855
Ridge 1by1 0.059 0.032 0.977 10.327
elastic net 0.2 1by1 0.058 0.030 0.978 9.752
elastic net 0.5 1by1 0.059 0.030 0.977 9.789
elastic net 0.8 1by1 0.059 0.030 0.977 9.821
mean 0.118 0.080 0.906 24.784
KNN 0.111 0.065 0.919 18.411
methyLImp 0.090 0.054 0.946 16.255
LASSO 0.088 0.053 0.949 15.661
Ridge 0.095 0.058 0.940 17.477
elastic net 0.2 0.089 0.054 0.948 16.032
Tumor elastic net 0.5 0.088 0.053 0.949 15.771
elastic net 0.8 0.088 0.053 0.949 15.797
FPCR 0.097 0.061 0.937 17.907
LASSO 1by1 0.087 0.052 0.950 15.264
Ridge 1by1 0.091 0.055 0.945 16.592
elastic net 0.2 1by1 0.086 0.051 0.951 15.182
elastic net 0.5 1by1 0.086 0.051 0.951 15.177
elastic net 0.8 1by1 0.087 0.051 0.951 15.219
methods have the lowest RMSE and highest PCC, The methyLImp method has the lowest 
MAE. The lowest MAPE is obtained by elastic net 0.2 1 by 1 method. In the Tumor group, 
the elastic net 0.2 1 by 1 method yields the lowest RMSE, MAE, MAPE and highest PCC.
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Table 3.4. Imputation accuracy for real data with 70% missing rate. The optimal value(s)
for each criteria are in bold.
RMSE MAE PCC MAPE
mean 0.085 0.054 0.952 16.657
KNN 0.108 0.059 0.923 25.502
methyLImp 0.063 0.032 0.974 10.593
LASSO 0.063 0.034 0.974 11.086
Ridge 0.063 0.034 0.974 11.131
elastic net 0.2 0.062 0.034 0.975 10.925
Normal elastic net 0.5
0.062 0.034 0.975 10.923
elastic net 0.8 0.063 0.034 0.974 10.920
FPCR 0.066 0.037 0.972 11.554
LASSO 1by1 0.064 0.033 0.973 10.725
Ridge 1by1 0.062 0.034 0.975 11.013
elastic net 0.2 1by1 0.062 0.033 0.975 10.540
elastic net 0.5 1by1 0.063 0.033 0.974 10.578
elastic net 0.8 1by1 0.064 0.033 0.973 10.680
mean 0.118 0.080 0.905 24.745
KNN 0.127 0.080 0.893 22.801
methyLImp 0.095 0.057 0.941 17.799
Tumor LASSO 0.097 0.059 0.938 17.774
Ridge 0.101 0.062 0.933 18.846
elastic net 0.2 0.096 0.059 0.939 18.043
elastic net 0.5 0.096 0.059 0.940 17.664
elastic net 0.8 0.096 0.059 0.939 17.642
FPCR 0.100 0.062 0.935 18.215
LASSO 1by1 0.096 0.057 0.939 17.040
Ridge 1by1 0.095 0.058 0.940 17.626
elastic net 0.2 1by1 0.093 0.055 0.943 16.688
elastic net 0.5 1by1 0.094 0.056 0.941 16.812
elastic net 0.8 1by1 0.095 0.056 0.941 16.917
3.4.3. DMR Detection. It is not possible to know the true regions that are differ­
entially methylated between Tumor and Normal groups in the real data. Thus the complete 
dataset described in Section 2.1.1 with the most information on hand is used as a standard
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for comparison. A potential false positive region is a region detected using the test data but 
not detected with the complete dataset. A potential false negative region is a region found 
by the complete dataset but not the test dataset.
Figure 3.5. Venn diagram of DMRs detected using incomplete, complete and imputed 
datasets.
Based on the imputation accuracy performance, elastic net 0.2 1 by 1 method is 
used to impute the missing values in the dataset. Then Bumphunter method is used to 
detect DMRs among incomplete, complete and imputed data. As shown in Figure 3.5, 
22 DMRs that overlap with the complete dataset are detected using the imputed data. 
This is an improvement compared to only 19 common DMRs between the incomplete and 
complete datasets. The number of potential false negative regions is reduced in the imputed 
dataset compared to the incomplete dataset. At the same time, the imputed dataset reduced 
the number of potential false positives to be only 1 compared to 7 using the incomplete 
dataset. Since the analysis on real data is conducted on a short section of Chromosome 1, 
these differences will accumulate when the entire genome is considered. More specifically, 
compared to a section with around 8000 probes, the entire genome has about 60 times more 
probes.
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3.5. RESULTS FOR SIMULATED DATA
The simulated data are filtered by the criteria introduced in Section 2.1.1. Effects 
are added to the 96 selected DMR clusters in the complete dataset with 36,279 probes. 
Missing values are introduced to the 4,917 probes that are restored from the SNP data with 
the missing rates of 20%, 50% and 70%. The imputation accuracy table and DMR detection 
performance for the methods are given below.
3.5.1. Im putation accuracy. Table 3.5 shows the imputation accuracy for the sim­
ulated data with 20% missing rate between the different imputation methods. The elastic 
net 0.5, elastic net 0.8, elastic net 0.2 1 by 1 and elastic net 0.5 1 by 1 methods have the 
lowest RMSE. The LASSO 1 by 1, elastic net 1 by 1 with mixing parameters 0.2, 0.5 and 
0.8 methods have the lowest MAE. All the elastic net methods and LASSO 1 by 1 yield the 
highest PCC. The elastic net 0.5 1 by 1 method has the lowest MAPE. For this missing rate, 
the overall performance of elastic net 0.5 1 by 1 method is the best.
Table 3.5. Imputation accuracy for simulated data with 20% missing rate. The optimal 
value(s) for each criteria are in bold.
RMSE MAE PCC MAPE
mean 0.090 0.058 0.953 19.627
KNN 0.070 0.040 0.972 13.020
methyLImp 0.069 0.036 0.973 12.490
LASSO 0.067 0.037 0.974 12.591
Ridge 0.071 0.037 0.972 12.584
elastic net 0.2 0.067 0.036 0.975 12.139
elastic net 0.5 0.066 0.036 0.975 12.072
elastic net 0.8 0.066 0.036 0.975 12.085
FPCR 0.074 0.043 0.969 13.874
LASSO 1by1 0.067 0.035 0.975 11.663
Ridge 1by1 0.067 0.037 0.974 12.287
elastic net 0.2 1by1 0.066 0.035 0.975 11.588
elastic net 0.5 1by1 0.066 0.035 0.975 11.580
elastic net 0.8 1by1 0.067 0.035 0.975 11.643
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Table 3.6 shows the imputation accuracy for simulated data with 50% missing rate. 
In terms of RMSE, elastic net 0.5 and Ridge 1 by 1 methods perform the best. Elastic net 0.2 
1 by 1 method yield the lowest MAE and MAPE. The elastic net (with mixing parameters 
0.2, 0.5, 0.8), Ridge 1 by 1, and elastic net 0.2 1 by 1 methods have the highest PCC. Table 
3.7 shows the imputation performance on simulated data with 70% missing rate. The Ridge 
1 by 1 method has the lowest RMSE and highest PCC. The elastic net 0.2 1 by 1 method 
has the lowest MAE and MAPE.
Table 3.6. Imputation accuracy for simulated data with 50% missing rate. The optimal 
value(s) for each criteria are in bold.
RMSE MAE PCC MAPE
mean 0.091 0.058 0.952 19.768
KNN 0.081 0.044 0.963 14.784
methyLImp 0.073 0.039 0.970 13.337
LASSO 0.072 0.041 0.970 13.779
Ridge 0.074 0.041 0.968 13.730
elastic net 0.2 0.072 0.040 0.971 13.445
elastic net 0.5 0.071 0.040 0.971 13.394
elastic net 0.8 0.072 0.040 0.971 13.478
FPCR 0.078 0.045 0.965 15.109
LASSO 1by1 0.074 0.040 0.969 13.233
Ridge 1by1 0.071 0.039 0.971 13.313
elastic net 0.2 1by1 0.072 0.038 0.971 12.912
elastic net 0.5 1by1 0.072 0.039 0.970 13.028
elastic net 0.8 1by1 0.073 0.039 0.969 13.146
The average running times in seconds on a MacBook Pro with Processor 2.7 GHz 
Intel Core i5 and Memory 8 GB 1867 MHz DDR3 over 30 runs for a select subset of the 
imputation methods are recorded. One of the standard regularized imputation methods 
(elastic net 0 .2), one of the 1 by 1 regularized imputation methods (elastic net 0.2 1 by 1) 
and the methyLImp method are compared. Elastic net 0.2 methods are chosen because they 
can represent other methods in the same method group, and their performance are stable 
among different settings. The elastic net 0.2 1 by 1 method is the fastest, while the elastic 
net 0.2 method is the slowest (Table 3.8).
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Table 3.7. Imputation accuracy for simulated data with 70% missing rate. The optimal
value(s) for each criteria are in bold.
RMSE MAE PCC MAPE
mean 0.092 0.059 0.951 20.534
KNN 0.114 0.066 0.925 31.077
methyLImp 0.078 0.043 0.965 15.027
LASSO 0.080 0.046 0.964 14.970
Ridge 0.080 0.046 0.964 14.991
elastic net 0.2 0.080 0.046 0.964 14.992
elastic net 0.5 0.080 0.046 0.964 14.991
elastic net 0.8 0.080 0.046 0.964 14.991
FPCR 0.083 0.048 0.961 15.488
LASSO 1by1 0.084 0.046 0.960 15.238
Ridge 1by1 0.077 0.044 0.966 14.416
elastic net 0.2 1by1 0.080 0.043 0.963 14.367
elastic net 0.5 1by1 0.081 0.044 0.962 14.630
elastic net 0.8 1by1 0.083 0.045 0.961 14.917
Table 3.8. Average running time in seconds over 30 runs
Average time (standard deviation)
elastic net 0.2 540.62 (9.87)
elastic net 0.2 1 by 1 57.87 (1.11)
methyLImp 59.99 (3.54)
Figure 3.6 provides a visualization of the RMSE verses the missing rate to compare 
the standard and 1 by 1 regularized methods in both the real and simulated data. The 
performance between the standard regularized imputation methods and the 1 by 1 methods 
are similar, yet the 1 by 1 methods are much more computationally efficient. Thus only the 
1 by 1 methods are further compared with other methods in Figure 3.7.
As a visualization and summary of Tables 3.2-3.7, Figure 3.7 compares the imputa­
tion accuracy of mean imputation, methyLImp, FPCR imputation and the 1 by 1 regularized 
methods with respect to RMSE for different missing rates in both the real and simulated 
data. The KNN method is not included in the figure since the RMSE is inflated dramatically
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Figure 3.6. The root mean square error (RMSE) verses missing rate to compare the standard 
regularized imputation methods and 1 by 1 regularized imputation methods. The standard 
regularized imputation methods and the 1 by 1 methods have similar performance.
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when the missing rate is high. The mean imputation method has the highest RMSE in all 
three datasets (real data Normal group, real data Tumor group and simulated data), followed 
by the FPCR method. The FPCR imputation has the second highest RMSE in all three 
datasets and for all missing rates, except for the simulated data at 70% missing rate. In 
the simulated data group with 70% missing rate, FPCR outperforms mean and LASSO 1 
by 1 methods. The methyLImp method is shown to have higher RMSE than all the 1 by 1 
regularized methods in the real data Normal group with missing rate 20% and 50%, and it 
only outperforms Ridge 1 by 1 and elastic net 0.8 1 by 1 methods with missing rate 70%. 
In this dataset, elastic net 0.2 1 by 1 method has the lowest RMSE at all missing rates. 
In the real data Tumor group, the elastic net methods have better performance in terms of 
RMSE than methyLImp. In the simulated data, all the regularized methods outperform 
methyLImp with 20% missing rate. Only the LASSO 1 by 1 method performed worse than 
methyLImp with 50% missing rate. The elastic net 0.2 1 by 1 method works the best in 
terms of MAE among all missing rates. When considering the overall imputation accuracy 
results across all datasets, the elastic net 0.2 1 by 1 method is recommended since it provides 
good performance and offers reasonable computational efficiency.
3.5.2. DMR detection. Using the 1 by 1 elastic net method with 0.2 mixing param­
eter recommended above, the DMR detection performance is assessed at the three different 
missing rates. Two DMR detection methods (Bumphunter and DMRcate) are applied. The 
regions detected as differentially methylated by both detection approaches are compared 
with the simulated true DMRs. Two regions are counted as overlapping if they share any 
common genomic locations on the chromosome. The relationship between two overlapping 
regions could be exactly the same (Figure 3.8 a), one region lying within the other (Figure 
3.8 b), or one region partially in common with the other (Figure 3.8 c). Alternatively, one 
region can also overlap with multiple regions (Figure 3.8 d).
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Figure 3.7. The root mean square error (RMSE) verses missing rate to compare the different 
imputation methods. The elastic net 0.2 1 by 1 method has good and stable performance 
across the three datasets and different missing rates.
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Figure 3.8. Different cases of overlapping regions: a) two regions are exactly the same, b) 
one region is within the other region, c) two regions have partial overlap, and d) one pink 
region overlaps with two green regions.
There are 96 true DMRs. Figure 3.9 shows Venn Diagrams comparing the overlap in 
detecting the true DMRs before and after imputation using the Bumphunter method for the 
three different missing rates. Before imputation, using the data with missing entries, only 
2 or 3 of the 96 DMRs can be found across the different missing rates. After imputation, 
46 or 47 of the true DMRs can be detected. There are two numbers in the intersection of 
the Venn Diagrams for the ‘After Imputation’ results because one true DMR is broken into 
two regions, as shown in Figure 3.8 d. Using the Bumphunter method, the number of true 
positives increases by 45 (2 to 47) with 20% missing rate, and 43 (3 to 46) with 50% and 
70% missing rates. The number of false positives also increases by 22 with all missing 
rates after the imputation method is applied. Figure 3.10 provides the results when the
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DMRcate method is used for DMR detection. The imputation step increased the number 
of true positives by 86, 88 and 88 respectively for missing rates 20%, 50% and 70%, while 
also increasing the number of false positives by 58, 80, and 81, respectively.
Figure 3.9. Venn diagrams to compare the DMRs found via the Bumphunter method before 
(top row) and after (bottom row) imputation to the true DMRs for different missing rates. 
When there are two numbers in the intersection, it means that one or more true regions are 
detected as multiple regions. Numbers in parentheses represent the number of true regions.
The proposed imputation method improved the DMR detection results despite the 
different DMR detection methods. To compare the DMR detection improvements among 
the two methods, Figure 3.11 shows the detected DMRs using the imputed dataset by 
Bumphunter method (blue) and DMRcate method (red) comparing to true DMRs (yellow) 
at different missing rates. The counts in the Venn diagrams are recorded in terms of the 
number of true DMRs in each part. These results show that the improvement on DMR
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Figure 3.10. Venn diagrams to compare the DMRs found via the DMRcate method before 
(top row) and after (bottom row) imputation to the true DMRs for different missing rates. 
When there are two numbers in the overlapping part, it means that one or more true regions 
are detected as multiple regions. Numbers in parentheses represent the number of true 
regions.
detection by using the proposed imputation method is consistent for both DMR detection 
methods. All the true positive regions detected by Bumphunter are also detected by 
DMRcate method at all missing rates.
3.6. DISCUSSION OF RESULTS
When analyzing the real data, the imputation accuracy shows an apparent difference 
between Tumor group and Normal group. For example, using the same imputation method 
elastic net 1 by 1 with mixing parameter 0 .2, and the 20% missing rate, the imputation 
accuracy in terms of RMSE is 0.059 in Normal group and 0.081 in Tumor group. The 
worst RMSE for the Normal group is 0.085 while the best RMSE for the Tumor group 
is 0.081. This may be caused by cancer heterogeneity. Previous research has shown the
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Figure 3.11. The detected DMRs using the imputed dataset by Bumphunter method (blue) 
and DMRcate method (red) compared to true DMRs (yellow). The counts of true DMRs 
are shown in the Venn diagrams.
existence of epigenetic heterogeneity among cancers (Liu et al., 2019; Teschendorff et al., 
2016; Fernandez et al., 2012). In the study of Fernandez et al. (2012), DNA methylation 
profiles of 1505 CpG sites were examined on normal tissues and tumor tissues. It was 
found that little variation exists in the DNA methylation patterns of normal tissues but there 
was greater methylation heterogeneity among tumors. Hansen et al. (2011) suggested that 
the epigenetic instability of essential genomic domains in tumor cells can lead to increased 
methylation variability, and then contribute to cancer heterogeneity. The high variability in 
the methylation levels in the Tumor group can lead to the low imputation accuracy.
The KNN imputation method performed poorly at missing rates 50% and 70% as 
seen in Tables 3.3, 3.4, 3.6, and 3.7. The maximum percent of missing data allowed in each 
variable is limited for the KNN method. When the percentage is over a threshold (usually 
50%), the missing value will be imputed using the overall mean of each sample. With 
a higher missing rate, KNN’s performance is even worse than mean imputation, because 
the mean imputation uses the mean over all samples with complete entries of a particular 
methylation site, while the KNN uses the mean over variables from the same sample.
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The functional principal component regression imputation methods does not per­
form as well as the regularized linear regression imputation. The reason is likely due to the 
large distance between probes. The human genome contains about 3 billion base pairs but 
is covered by only around 450,000 probes on the microarray. Although probes are more 
dense in some regions, on average neighboring probes may be too far away to maintain the 
correlation mentioned in Section 2.1.2.
To summarize, the regularized linear regression imputation methods proposed in 
this work have outperformed methyLImp in terms of RMSE, PCC and MAPE for the real 
data under different missing rates. For simulated data, the regularized linear regression 
imputation methods have better performance than methyLImp in terms of all four criteria 
(RMSE, MAE, PCC and MAPE) under all missing rates. The 1 by 1 regularized methods 
are more computationally efficient without much sacrifice in performance compared to the 
regularized methods. The elastic net 0.2 1 by 1 method is recommended based on its 
overall stable and good performance across most settings. While applying the imputation 
methods for DMR analysis, true positive detection are improved. Although the number 
of false positive detections also increased after imputation, the increase is small compared 
to the increase of true positive detections. Take the 20% missing rate for example, using 
the Bumphunter method, the number of true positives increased by 22.5 times (2 to 47) 
while the number of false positives increased by 0.35 times (62 to 84). Using the DMRcate 
method, the number of true positives increased by 21.5 times (4 to 90) while the number of 




The filtering out of potential single nucleotide polymorphism (SNP) probes in the 
preprocessing step of DNA differential methylation studies causes an unnecessary waste 
of information. Incorporating SNP data into the DNA methylation analysis framework, 
allows a large proportion of the probes to be restored. The effects of recovering those 
probes are remarkable. The improvement on increasing the number of true DMRs has been 
demonstrated by both the real data analysis and simulation studies, which only utilize part 
of the genome. The effects will accumulate when the entire genome is considered.
In this research, SNP data are integrated with Infinium HumanMethylation450 
BeadChip (HM450) methylation data to recover potential SNP-probes that do not actually 
have SNPs and apply novel imputation methods for missing data due to true SNPs or 
for other reasons. Missing data are categorized according to their missing mechanism as 
missing completely at random, missing at random or missing not at random. Missing DNA 
methylation data because of filtering is assumed to fall into the missing at random category. 
Missing rates of 20%, 50% and 70% are used to develop and test the proposed methodology.
Imputation methods are proposed in Chapter 2 for DNA methylation data. Several 
regularized regression methods are proposed, along with a functional data approach, and 
compared to three existing methods. Previous studies have shown that methylation levels 
are correlated with neighboring probes within short distances on the chromosome (Eckhardt 
et al., 2006). It has also been found that the methylation levels are highly correlated with 
other probes from the same sample (Zhang et al., 2015). This information can be used to aid 
in imputing missing methylation levels. For each probe with missing values, submatrices 
are extracted from the data to fit a regression model that is used to attain the imputed values.
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The model is fit by using the available data at the missing probe as the response variable and 
data from other probes with complete information as the predictor variables. The imputation 
steps in this research iteratively evaluate all subsets of probes with missing entries. The 
input data is organized with each row representing a sample and each column representing 
a probe. First a predictive model is built under the regularized linear regression framework, 
then the missing values are imputed by prediction using complete entries of the same 
sample. Ridge, LASSO and elastic net regression are explored as shrinkage approaches. 
The tuning parameter that determines the amount of shrinkage for each model is selected 
by cross validation. This step makes the computational speed slow because cross validation 
is needed for each iteration. Therefore, variable screening before the regularization step 
is recommended. Also, imputing the missing values site by site is recommended since 
two sites may have different sets of most correlated predictors. The selection criteria for 
including variables in the model is the Pearson correlation between the predictors and the 
response variable. The number of probes used in the regression model is set to be the same 
as the number of samples in the model. In an alternative approach, the measurements of 
each sample are treated as one observation with a smooth curve representing the underlying 
structure based on the correlation between neighboring probes of DNA methylation data. 
Functional principal component analysis is performed and the component scores are used as 
inputs into a functional linear regression model, which is used to perform the imputations.
The proposed imputation methods are evaluated and compared to existing methods 
using both real and simulated data. A simulation study is conducted based on real data to 
keep the natural structure of the DNA methylation data. Adjacent site clustering is applied 
to reveal potential clusters (regions) using the normal samples of the real data. Among these 
clusters, a subset is randomly selected in which known effects are added to differentiate 
the two groups. Considering hyper- and hypomethylation patterns in the human genome 
(Peters et al., 2015), two types of simulated regions are applied. For 50% of the clusters,
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the effect is added to the entire cluster. For the other 50% of the clusters, the effect is added 
at the probe resolution, meaning that only the probe with high group mean will have the 
effect added to the specific probe.
Performance of the proposed methods is assessed by two aspects. The first is the 
imputation accuracy. The regularized methods have the best overall performance with 
respect to imputation accuracy, followed by methyLImp, then FPCR imputation. The 
traditional imputation methods such as mean and KNN imputation perform worse. In terms 
of computational efficiency, the regularized 1 by 1 approach is more efficient with similar 
imputation accuracy as the regularized methods. The second way imputation performance 
is evaluated is by investigating the impact on DMR detection. Using simulated data with 
true DMRs known, imputation using the 1 by 1 approach for the elastic net with mixing 
parameter 0.2 increased the number of true positives and decreased the number of false 
negatives compared to analyzing the data without doing imputation. The number of false 
positive detections also increased with the imputed dataset, but this increase was minimal 
compared to the increase in true positive detections.
4.2. FUTURE WORK
In this research, efforts have been focused on restoring the probes that are filtered 
out of HM450 data for the reason of potentially having a SNP. According to Table 3.1, high 
detection p-values are another main reason for probe filtering. Those probes are removed 
because they are carrying mainly noise instead of methylation information. Imputation and 
simulation studies can be conducted to improve the DMR detection ability of the regions 
involving those probes. Also, methods and theory can be tested and modified for other 
types of DNA methylation data such as Illumina Infinium Methylation EPIC array and next 
generation sequencing data. The FPCR method has a high potential to show improvement 
on whole genome bisulfite sequencing (WGBS) data due to the comprehensive and dense
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coverage of the genome it provides. The proposed methods in this study incorporate 
the correlation between genomic variables into the imputation process, so they may be 
generalized to other genomic data such as gene expression data.
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